Amedeo Smart

Free Medical Literature Service

 

Amedeo

Gynecology
  Free Subscription

Articles published in
PLoS One
    January 2024
  1. ALJREES T
    Improving prediction of cervical cancer using KNN imputer and multi-model ensemble learning.
    PLoS One. 2024;19:e0295632.
    >> Share

  2. WANG Y, Chen L, Tao Y, Luo M, et al
    Risk factors of ectopic pregnancy after in vitro fertilization-embryo transfer in Chinese population: A meta-analysis.
    PLoS One. 2024;19:e0296497.
    >> Share

  3. YOO MY, Woo KJ, Kang SY, Moon BS, et al
    Efficacy of preoperative lymphoscintigraphy in predicting surgical outcomes of lymphaticovenous anastomosis in lower extremity lymphedema: Clinical correlations in gynecological cancer-related lymphedema.
    PLoS One. 2024;19:e0296466.
    >> Share

  4. MUNSHI RM
    Novel ensemble learning approach with SVM-imputed ADASYN features for enhanced cervical cancer prediction.
    PLoS One. 2024;19:e0296107.
    >> Share

  5. YU C, Wu X, Zhang S, Zhang L, et al
    Prognostic model for survival in patients with neuroendocrine carcinomas of the cervix: SEER database analysis and a single-center retrospective study.
    PLoS One. 2024;19:e0296446.
    >> Share

  6. WANG G, Fu J, Liu M, Zheng Q, et al
    CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma.
    PLoS One. 2024;19:e0277872.
    >> Share

  7. GUILLAUME D, Waheed DE, Schleiff M, Muralidharan KK, et al
    Global perspectives of determinants influencing HPV vaccine introduction and scale-up in low- and middle-income countries.
    PLoS One. 2024;19:e0291990.
    >> Share

  8. XIE B, Liao M, Huang Y, Hang F, et al
    Association between vitamin D and endometriosis among American women: National Health and Nutrition Examination Survey.
    PLoS One. 2024;19:e0296190.
    >> Share

  9. YI L, Huang B, Liu Y, Zhou L, et al
    Acupuncture therapies for relieving pain in pelvic inflammatory disease: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0292166.
    >> Share

  10. ROBBINS SJ, Brown SE, Stennett CA, Tuddenham S, et al
    Uterine fibroids and longitudinal profiles of the vaginal microbiota in a cohort presenting for transvaginal ultrasound.
    PLoS One. 2024;19:e0296346.
    >> Share

  11. SARMIENTO-MEDINA MI, de Amaya MP, Villamizar-Gomez L, Gonzalez-Coba AC, et al
    High-risk HPV prevalence and vaccination coverage among Indigenous women in the Colombian Amazon: Implications for cervical cancer prevention. Cross-sectional study.
    PLoS One. 2024;19:e0297579.
    >> Share

  12. YONG CM, Yehgambaram PAP, Lee SWH
    Cost-effectiveness analysis of olaparib maintenance therapy for BRCA mutation ovarian cancer in the public sector in Malaysia.
    PLoS One. 2024;19:e0298130.
    >> Share

  13. DING H, Hu B, Guo R
    Comprehensive analysis of single cell and bulk data develops a promising prognostic signature for improving immunotherapy responses in ovarian cancer.
    PLoS One. 2024;19:e0298125.
    >> Share

  14. MANGENAH C, Sibanda EL, Maringwa G, Sithole J, et al
    Provider and female client economic costs of integrated sexual and reproductive health and HIV services in Zimbabwe.
    PLoS One. 2024;19:e0291082.
    >> Share

  15. YANG T, Li J, Zhang Y, Deng Z, et al
    Intracellular presence of Helicobacter pylori antigen and genes within gastric and vaginal Candida.
    PLoS One. 2024;19:e0298442.
    >> Share

  16. VARON ML, Geng Y, Fellman BM, Troisi C, et al
    Interventions to increase follow-up of abnormal cervical cancer screening results: A systematic literature review and meta-analysis.
    PLoS One. 2024;19:e0291931.
    >> Share

  17. KISER AC, Schliep KC, Hernandez EJ, Peterson CM, et al
    An artificial intelligence approach for investigating multifactorial pain-related features of endometriosis.
    PLoS One. 2024;19:e0297998.
    >> Share

  18. KANG SW, Kang OJ, Lee JY, Kim H, et al
    Evaluation of the anti-cancer efficacy of lipid nanoparticles containing siRNA against HPV16 E6/E7 combined with cisplatin in a xenograft model of cervical cancer.
    PLoS One. 2024;19:e0298815.
    >> Share

  19. SUN J, Frick KD, Liang H, Chow CM, et al
    Examining cancer screening disparities by race/ethnicity and insurance groups: A comparison of 2008 and 2018 National Health Interview Survey (NHIS) data in the United States.
    PLoS One. 2024;19:e0290105.
    >> Share

  20. STAN A, Bosart K, Kaur M, Vo M, et al
    Detection of driver mutations and genomic signatures in endometrial cancers using artificial intelligence algorithms.
    PLoS One. 2024;19:e0299114.
    >> Share

  21. TABBARA F, Hariri M, Hitti E
    Ovarian torsion: A retrospective case series at a tertiary care center emergency department.
    PLoS One. 2024;19:e0297690.
    >> Share

  22. YAO B, Peng J, Song W, Yang L, et al
    Real-world effectiveness of cytology and HPV-based screening strategy in cervical cancer screening: A cross-sectional population-based study in Chengdu, China.
    PLoS One. 2024;19:e0299651.
    >> Share

  23. ZHANG J, Yuan J, Zhang D, Yang Y, et al
    Short video platforms as sources of health information about cervical cancer: A content and quality analysis.
    PLoS One. 2024;19:e0300180.
    >> Share

  24. CAROZZI FM, Royder Yanez R, Paganini I, Sani C, et al
    Cervical cancer prevention: Feasibility of self-sampling and HPV testing in rural and urban areas of Bolivia: An observational study.
    PLoS One. 2024;19:e0292605.
    >> Share

  25. LIU Z, Fan T, Mo X, Kan J, et al
    Association between multiple sclerosis and cancer risk: A two-sample Mendelian randomization study.
    PLoS One. 2024;19:e0298271.
    >> Share

  26. MIKHAEL S, Kurdi A, Khoueiry-Zgheib N, Tahtouh R, et al
    Evaluating synergistic effects of metformin and simvastatin on ovarian cancer cells.
    PLoS One. 2024;19:e0298127.
    >> Share

  27. LIN Y, Long Y, He J, Yi Q, et al
    The residual rate of HPV and the recurrence rate of CIN after LEEP with negative margins: A meta-analysis.
    PLoS One. 2024;19:e0298520.
    >> Share

  28. KANG J, Na K, Kang H, Cho U, et al
    Prediction of homologous recombination deficiency from Oncomine Comprehensive Assay Plus correlating with SOPHiA DDM HRD Solution.
    PLoS One. 2024;19:e0298128.
    >> Share

  29. DONG C, Zhao L, Liu X, Dang L, et al
    Single-cell analysis reveals landscape of endometrial cancer response to estrogen and identification of early diagnostic markers.
    PLoS One. 2024;19:e0301128.
    >> Share

  30. AN G, Zhao X, Zhao C
    Unraveling the causal association between leukocyte telomere length and infertility: A two-sample Mendelian randomization study.
    PLoS One. 2024;19:e0298997.
    >> Share

  31. XIE N, Wang F, Chen D, Zhou J, et al
    Immune dysfunction mediated by the competitive endogenous RNA network in fetal side placental tissue of polycystic ovary syndrome.
    PLoS One. 2024;19:e0300461.
    >> Share

  32. CANING MM, Rasmussen SC, Krebs L
    Maternal outcomes of planned mode of delivery for term breech in nulliparous women.
    PLoS One. 2024;19:e0297971.
    >> Share

  33. LI L, He L, Guo W, Ma J, et al
    PMFFNet: A hybrid network based on feature pyramid for ovarian tumor segmentation.
    PLoS One. 2024;19:e0299360.
    >> Share

  34. BAO H, Cong J, Qu Q, He S, et al
    Rosiglitazone alleviates LPS-induced endometritis via suppression of TLR4-mediated NF-kappaB activation.
    PLoS One. 2024;19:e0280372.
    >> Share

  35. BAE JS, Lee JY, Chung HH, Lee M, et al
    Optimized treatment parameter by computer simulation for high-intensity focused ultrasound treatment of uterine adenomyosis: Short-term and long-term results.
    PLoS One. 2024;19:e0301193.
    >> Share

  36. OOMMEN AM, Isaac R, Paul B, Weller D, et al
    Strategies for primary HPV test-based cervical cancer screening programme in resource-limited settings in India: Results from a quasi-experimental pragmatic implementation trial.
    PLoS One. 2024;19:e0301385.
    >> Share

  37. MEHRA T, Lupatsch JE, Kossler T, Dedes K, et al
    Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer.
    PLoS One. 2024;19:e0301271.
    >> Share

    January 2023
  38. BUNTING SR, Morris S, Chael J, Feinstein BA, et al
    Knowledge of human papillomavirus vaccination: A multi-institution, cross-sectional study of allopathic and osteopathic medical students.
    PLoS One. 2023;18:e0280287.
    >> Share

  39. FIRAT A, Ercan A, Mordeniz C, Verit Atmaca FF, et al
    Predictive value of hemogram parameters in malignant transformation of the endometrium in patients with different risk factors.
    PLoS One. 2023;18:e0279224.
    >> Share

  40. HOSSAIN MA, Sohel M, Rahman MH, Hasan MI, et al
    Bioinformatics and In silico approaches to identify novel biomarkers and key pathways for cancers that are linked to the progression of female infertility: A comprehensive approach for drug discovery.
    PLoS One. 2023;18:e0265746.
    >> Share

  41. ABERA GB, Yebyo HG, Hailekiros H, Niguse S, et al
    Epidemiology of pre-cancerous cervical lesion and risk factors among adult women in Tigray, Ethiopia.
    PLoS One. 2023;18:e0280191.
    >> Share

  42. YOSHIDA-COURT K, Karpinets TV, Mitra A, Solley TN, et al
    Immune environment and antigen specificity of the T cell receptor repertoire of malignant ascites in ovarian cancer.
    PLoS One. 2023;18:e0279590.
    >> Share

  43. KAMBOJ N, Saraswathy KN, Prasad S, Babu N, et al
    Women infertility and common mental disorders: A cross-sectional study from North India.
    PLoS One. 2023;18:e0280054.
    >> Share

  44. FELEKE G, Tantu T, Zewdu D, Gedefawu A, et al
    Case-control study on determinants of uterine rupture among mothers who gave birth at Hawassa University comprehensive specialized hospital.
    PLoS One. 2023;18:e0279175.
    >> Share

  45. ENGEVIK KA, Engevik MA, Engevik AC
    Bioinformatics reveal elevated levels of Myosin Vb in uterine corpus endometrial carcinoma patients which correlates to increased cell metabolism and poor prognosis.
    PLoS One. 2023;18:e0280428.
    >> Share

  46. NARTEY Y, Amo-Antwi K, Hill PC, Dassah ET, et al
    Human papillomavirus genotype distribution among women with and without cervical cancer: Implication for vaccination and screening in Ghana.
    PLoS One. 2023;18:e0280437.
    >> Share

  47. VILLAVICENCIO A, Kelsey G, Nogueira NF, Zukerberg J, et al
    Knowledge, attitudes, and practices towards HPV vaccination among reproductive age women in a HIV hotspot in the US.
    PLoS One. 2023;18:e0275141.
    >> Share

  48. RAO JS, Kobetz E, Yu H, Baeker-Bispo J, et al
    Partially Recursively Induced Structured Moderation (PRISM) for modeling racial differences in endometrial cancer survival.
    PLoS One. 2023;18:e0268221.
    >> Share

  49. DE FOUW M, Stroeken Y, Niwagaba B, Musheshe M, et al
    Involving men in cervical cancer prevention; a qualitative enquiry into male perspectives on screening and HPV vaccination in Mid-Western Uganda.
    PLoS One. 2023;18:e0280052.
    >> Share

  50. CARMICHAEL MM, Alchaar I, Davis KA, Krevosky MK, et al
    The small heat shock protein alphaB-Crystallin protects versus withaferin A-induced apoptosis and confers a more metastatic phenotype in cisplatin-resistant ovarian cancer cells.
    PLoS One. 2023;18:e0281009.
    >> Share

  51. KRAUT R, Carvallo FD, Golonka R, Campbell SM, et al
    Scoping review of cytolytic vaginosis literature.
    PLoS One. 2023;18:e0280954.
    >> Share

  52. OKUNADE KS, Badmos KB, Okoro AC, Ademuyiwa IY, et al
    Comparative Assessment of p16/Ki-67 Dual Staining Technology for cervical cancer screening in women living with HIV (COMPASS-DUST)-Study protocol.
    PLoS One. 2023;18:e0278077.
    >> Share

  53. FLEIDER LA, de Los Angeles Tinnirello M, Gomez Cherey F, Garcia MG, et al
    High sensitivity and specificity rates of cobas(R) HPV test as a primary screening test for cervical intraepithelial lesions in a real-world setting.
    PLoS One. 2023;18:e0279728.
    >> Share

  54. WONGJAMPA W, Nakahara T, Tanaka K, Yugawa T, et al
    An in vitro carcinogenesis model for cervical cancer harboring episomal form of HPV16.
    PLoS One. 2023;18:e0281069.
    >> Share

  55. JANG YS, Kim TW, Ryu JS, Kong HJ, et al
    Upregulation of programmed death ligand-1 in tumor-associated macrophages affects chemotherapeutic response in ovarian cancer cells.
    PLoS One. 2023;18:e0277285.
    >> Share

  56. JANA B, Calka J
    Effect of blocking of alpha1-adrenoreceptor isoforms on the noradrenaline-induced changes in contractility of inflamed pig uterus.
    PLoS One. 2023;18:e0280152.
    >> Share

  57. ZHOU J, Jiang Z, Fu L, Qu F, et al
    Contribution of labor related gene subtype classification on heterogeneity of polycystic ovary syndrome.
    PLoS One. 2023;18:e0282292.
    >> Share

  58. KREMER F, Ditzen B, Wischmann T
    Effectiveness of psychosocial interventions for infertile women: A systematic review and meta-analysis with a focus on a method-critical evaluation.
    PLoS One. 2023;18:e0282065.
    >> Share

  59. WEI Y, Wang S
    Comparison of emergency cervical cerclage and expectant treatment in cervical insufficiency in singleton pregnancy: A meta-analysis.
    PLoS One. 2023;18:e0278342.
    >> Share

  60. FELL C, Mohammadi M, Morrison D, Arandjelovic O, et al
    Detection of malignancy in whole slide images of endometrial cancer biopsies using artificial intelligence.
    PLoS One. 2023;18:e0282577.
    >> Share

  61. YAN L, Xiao X, He L, Shi L, et al
    Efficacy of optical coherence tomography in the triage of women with minor abnormal cervical cytology before colposcopy.
    PLoS One. 2023;18:e0282833.
    >> Share

  62. REZENDE GP, Yela Gomes DA, Benetti-Pinto CL
    Prevalence of abnormal uterine bleeding in Brazilian women: Association between self-perception and objective parameters.
    PLoS One. 2023;18:e0282605.
    >> Share

  63. CHOI J, Markham C, Tami-Maury I, Kim S, et al
    Maternal perceptions of vaccinating boys against human papillomavirus (HPV) in Seoul, South Korea: A descriptive exploratory qualitative study.
    PLoS One. 2023;18:e0282811.
    >> Share

  64. LEE YE, Park S, Lee KY, Song JE, et al
    Risk factors based on myoma characteristics for predicting postoperative complications following cesarean myomectomy.
    PLoS One. 2023;18:e0280953.
    >> Share

  65. RODRIGUEZ NM, Brennan LP, Claure L, Balian LN, et al
    Leveraging COVID-era innovation for cervical cancer screening: Clinician awareness and attitudes toward self-sampling and rapid testing for HPV detection.
    PLoS One. 2023;18:e0282853.
    >> Share

  66. BREDIN HK, Krakstad C, Hoivik EA
    PIK3CA mutations and their impact on survival outcomes of patients with endometrial cancer: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0283203.
    >> Share

  67. POMERANZ M, Schonman R, Yagur Y, Tamir Yaniv R, et al
    An intrauterine cavity morcellator: A novel approach to high volume uterus morcellation. Ex-vivo study.
    PLoS One. 2023;18:e0282149.
    >> Share

  68. EBRING C, Marlin R, Macni J, Vallard A, et al
    Type II endometrial cancer: Incidence, overall and disease-free survival in Martinique.
    PLoS One. 2023;18:e0278757.
    >> Share

  69. EDZIE EKM, Dzefi-Tettey K, Brakohiapa EK, Quarshie F, et al
    Age of first diagnosis and incidence rate of uterine fibroids in Ghana. A retrospective cohort study.
    PLoS One. 2023;18:e0283201.
    >> Share

  70. NUNES PEREIRA P, Francoise Derchain S, Yoshida A, Hoelz de Oliveira Barros R, et al
    Diffusion-weighted magnetic resonance sequence and CA125/CEA ratio can be used as add-on tools to ultrasound for the differentiation of ovarian from non-ovarian pelvic masses.
    PLoS One. 2023;18:e0283212.
    >> Share

  71. FILIPPI F, Reschini M, Polledri E, Cecchele A, et al
    Progestin-primed ovarian stimulation for fertility preservation in women with cancer: A comparative study.
    PLoS One. 2023;18:e0280238.
    >> Share

  72. GIBSON-HELM M, Slater T, MacDonald EJ, Stevenson K, et al
    Te Ara Waiora-Implementing human papillomavirus (HPV) primary testing to prevent cervical cancer in Aotearoa New Zealand: A protocol for a non-inferiority trial.
    PLoS One. 2023;18:e0280643.
    >> Share

  73. HAWARDEN A, Price M, Russell B, Wilson G, et al
    A three protein signature fails to externally validate as a biomarker to predict surgical outcome in high-grade epithelial ovarian cancer.
    PLoS One. 2023;18:e0281798.
    >> Share

  74. SMITH JS, Vaz OM, Gaber CE, Des Marais AC, et al
    Recruitment strategies and HPV self-collection return rates for under-screened women for cervical cancer prevention.
    PLoS One. 2023;18:e0280638.
    >> Share

  75. JLASSI A, Manai M, Morjen M, Sahraoui G, et al
    VISTA+/CD8+ status correlates with favorable prognosis in Epithelial ovarian cancer.
    PLoS One. 2023;18:e0278849.
    >> Share

  76. PARADA LRC, Turri JAO, Helena da Costa V, Vieira IB, et al
    Non-oncological gynecological diagnoses in a women's health care service during the pandemic caused by the Severe Acute Respiratory Syndrome Coronavirus 2.
    PLoS One. 2023;18:e0282039.
    >> Share

  77. PAKEN J, Govender CD, Pillay M, Feyasa M, et al
    Cisplatin-associated ototoxicity amongst cervical cancer patients: A prospective cohort study in south Africa.
    PLoS One. 2023;18:e0283639.
    >> Share

  78. TAKADA A, Yokota H, Nemoto MW, Horikoshi T, et al
    Prognosis prediction of uterine cervical cancer using changes in the histogram and texture features of apparent diffusion coefficient during definitive chemoradiotherapy.
    PLoS One. 2023;18:e0282710.
    >> Share

  79. KITAMURA A, Jiayue C, Suwa T, Kato Y, et al
    Neonatal administration of synthetic estrogen, diethylstilbestrol to mice up-regulates inflammatory Cxclchemokines located in the 5qE1 region in the vaginal epithelium.
    PLoS One. 2023;18:e0280421.
    >> Share

  80. KYVERNITAKIS I, Lauer P, Malan M, Badir S, et al
    A novel aspiration technique to assess cervical remodelling in patients with or without cervical shortening: Sequence of first changes, definition of cut-off values and impact of cervical pessary, stratified for cervical length.
    PLoS One. 2023;18:e0283944.
    >> Share

  81. GOLDSBURY DE, Vassallo A, Weber MF, Steinberg J, et al
    Health services costs for ovarian cancer in Australia: Estimates from the 45 and Up Study.
    PLoS One. 2023;18:e0282851.
    >> Share

  82. HURT K, Zahalka F, Zikan M, Rackova J, et al
    Hypoxia as a potential cause of dyspareunia.
    PLoS One. 2023;18:e0281268.
    >> Share

  83. WANG L, Tang Y, Wang Y
    Predictors and incidence of depression and anxiety in women undergoing infertility treatment: A cross-sectional study.
    PLoS One. 2023;18:e0284414.
    >> Share

  84. SAJO AE, Mouton A, Olorunfemi G, Cathy V, et al
    Evaluation of the medically necessary, time sensitive triage score during and beyond the local COVID-19 pandemic in the Gynaecologic Oncology Unit of a tertiary hospital in South Africa.
    PLoS One. 2023;18:e0284177.
    >> Share

  85. HU PW, Yang BR, Zhang XL, Yan XT, et al
    The association between dietary inflammatory index with endometriosis: NHANES 2001-2006.
    PLoS One. 2023;18:e0283216.
    >> Share

  86. LIVESEY M, Rossouw SC, Blignaut R, Christoffels A, et al
    Transforming RNA-Seq gene expression to track cancer progression in the multi-stage early to advanced-stage cancer development.
    PLoS One. 2023;18:e0284458.
    >> Share

  87. KIM NK, Suh DH, Kim K, Kim YB, et al
    Feasibility of extended cycles of neoadjuvant chemotherapy in patients with advanced ovarian cancer in terms of prognosis and surgical outcomes.
    PLoS One. 2023;18:e0284753.
    >> Share

  88. OKAFOR IP, Kukoyi FO, Kanma-Okafor OJ, Izuka MO, et al
    Male involvement in female partners' screening for breast and cervical cancers in Southwest Nigeria.
    PLoS One. 2023;18:e0284141.
    >> Share

  89. MITI S, Shato T, Asante C, Baumann A, et al
    Leveraging health infrastructure to optimize HPV vaccination for adolescents in Zambia: Protocol for an implementation study.
    PLoS One. 2023;18:e0285031.
    >> Share

  90. WU X, Lu W, Jiang C, Zhang D, et al
    Effect of ERCC1 polymorphisms on the response to platinum-based chemotherapy: A systematic review and meta-analysis based on Asian population.
    PLoS One. 2023;18:e0284825.
    >> Share

  91. LOPACINSKA-JORGENSEN J, Petersen PHD, Oliveira DVNP, Hogdall CK, et al
    Strategies for data normalization and missing data imputation and consequences for potential diagnostic microRNA biomarkers in epithelial ovarian cancer.
    PLoS One. 2023;18:e0282576.
    >> Share

  92. HOLOPAINEN E, Lahtinen O, Kononen M, Anttila M, et al
    Greater increases in intratumoral apparent diffusion coefficients after chemoradiotherapy predict better overall survival of patients with cervical cancer.
    PLoS One. 2023;18:e0285786.
    >> Share

  93. BAHRAMI F, Maheux-Lacroix S, Bougie O, Boutin A, et al
    Complications following surgeries for endometriosis: A systematic review protocol.
    PLoS One. 2023;18:e0285929.
    >> Share

  94. KHOMPHAIBOONKIJ U, Sreamsukcharoenchai N, Pitakkarnkul S, Rittiluechai K, et al
    Knowledge of Thai women in cervical cancer etiology and screening.
    PLoS One. 2023;18:e0286011.
    >> Share

  95. KURITA Y, Meguro S, Tsuyama N, Kosugi I, et al
    Accurate deep learning model using semi-supervised learning and Noisy Student for cervical cancer screening in low magnification images.
    PLoS One. 2023;18:e0285996.
    >> Share

  96. DA SILVA JL, de Albuquerque LZ, Rodrigues FR, Bastos NC, et al
    Exploring biomarkers and prognostic factors in uterine carcinosarcoma: An insight into L1CAM, CDX2, p53, and MSI status.
    PLoS One. 2023;18:e0285447.
    >> Share

  97. PANERU B, Karmacharya A, Bharati A, Makaju S, et al
    Association between cancer stigma and cervical cancer screening uptake among women of Dhulikhel and Banepa, Nepal.
    PLoS One. 2023;18:e0285771.
    >> Share

  98. JEMAL Z, Chea N, Hasen H, Tesfaye T, et al
    Cervical cancer screening utilization and associated factors among female health workers in public health facilities of Hossana town, southern Ethiopia: A mixed method approach.
    PLoS One. 2023;18:e0286262.
    >> Share

  99. MWENDA V, Bor JP, Nyangasi M, Njeru J, et al
    Integrating human papillomavirus testing as a point-of care service using GeneXpert platforms: Findings and lessons from a Kenyan pilot study (2019-2020).
    PLoS One. 2023;18:e0286202.
    >> Share

  100. RIZVI M, Islam MA, Aftab MT, Naqvi AA, et al
    Knowledge, attitude, and perceptions about polycystic ovarian syndrome, and its determinants among Pakistani undergraduate students.
    PLoS One. 2023;18:e0285284.
    >> Share

  101. NOGUEIRA NF, Luisi N, Salazar AS, Cherenack EM, et al
    PrEP awareness and use among reproductive age women in Miami, Florida.
    PLoS One. 2023;18:e0286071.
    >> Share

  102. SODERMAN L, Bottiger Y, Edlund M, Jarnbert-Pettersson H, et al
    Adjuvant use of melatonin for pain management in endometriosis-associated pelvic pain-A randomized double-blinded, placebo-controlled trial.
    PLoS One. 2023;18:e0286182.
    >> Share

  103. ALAM Z, Cairns JM, Scott M, Dean JA, et al
    Interventions to increase cervical screening uptake among immigrant women: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0281976.
    >> Share

  104. VAINER G, Huang L, Emancipator K, Nuti S, et al
    Equivalence of laboratory-developed test and PD-L1 IHC 22C3 pharmDx across all combined positive score indications.
    PLoS One. 2023;18:e0285764.
    >> Share

  105. ANCHOORI RK, Anchoori V, Lam B, Tseng SH, et al
    Development and anticancer properties of Up284, a spirocyclic candidate ADRM1/RPN13 inhibitor.
    PLoS One. 2023;18:e0285221.
    >> Share

  106. LIU H, Ma S, Chen X, Wu H, et al
    Diagnostic accuracy of the Copenhagen Index in ovarian malignancy: A meta-analysis.
    PLoS One. 2023;18:e0286650.
    >> Share

  107. FUJITA M, Nagashima K, Shimazu M, Suzuki M, et al
    Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial.
    PLoS One. 2023;18:e0286909.
    >> Share

  108. SAMA SR, Gore R, Bauer AZ, Garber L, et al
    Targeting patients for early COVID-19 therapy; Pre-infection metabolic dysfunction, polycystic ovary syndrome and risk of severe disease in patients under 65: A Massachusetts community-based observational study.
    PLoS One. 2023;18:e0287430.
    >> Share

  109. JONSDOTTIR B, Wikman A, Sundstrom Poromaa I, Stalberg K, et al
    Advanced gynecological cancer: Quality of life one year after diagnosis.
    PLoS One. 2023;18:e0287562.
    >> Share

  110. DIVINCENZO MJ, Angell CD, Suarez-Kelly LP, Ren C, et al
    Expression of microRNAs and their target genes in melanomas originating from gynecologic sites.
    PLoS One. 2023;18:e0285804.
    >> Share

  111. ALAM F, Shahid M, Riffat S, Zulkipli IN, et al
    SIRT1 and antioxidants in infertile females: Exploration of the role of vitamin D.
    PLoS One. 2023;18:e0287727.
    >> Share

  112. STRBAC M, Vukovic V, Pustahija T, Nikolic N, et al
    Motives and attitudes of parents toward HPV vaccination: Results from the initial period of HPV vaccine rollout in Serbia.
    PLoS One. 2023;18:e0287295.
    >> Share

  113. WULANDARI D, Meidyandra RW, Andrijono
    Genotype profiles of high-risk human papillomavirus in women of reproductive age: A community-based study.
    PLoS One. 2023;18:e0287399.
    >> Share

  114. MAHAJAN H, Reddy N, Devi NGM, Poli UR, et al
    Projected cancer burden, challenges, and barriers to cancer prevention and control activities in the state of Telangana.
    PLoS One. 2023;18:e0278357.
    >> Share

  115. FAZLOLLAHPOUR-NAGHIBI A, Bagheri K, Almukhtar M, Taha SR, et al
    Trichomonas vaginalis infection and risk of cervical neoplasia: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0288443.
    >> Share

  116. SHI K, Liu XL, Guo Q, Zhang YQ, et al
    TMEM41A overexpression correlates with poor prognosis and immune alterations in patients with endometrial carcinoma.
    PLoS One. 2023;18:e0285817.
    >> Share

  117. BAS S, Sijben J, Bischoff EWMA, Bekkers RLM, et al
    Acceptability of risk-based triage in cervical cancer screening: A focus group study.
    PLoS One. 2023;18:e0289647.
    >> Share

  118. CONTRERAS NE, Roldan JS, Castillo DS
    Novel competitive enzyme-linked immunosorbent assay for the detection of the high-risk Human Papillomavirus 18 E6 oncoprotein.
    PLoS One. 2023;18:e0290088.
    >> Share

  119. CHEN B, Lu X, Zhou Q, Chen Q, et al
    PAXIP1-AS1 is associated with immune infiltration and predicts poor prognosis in ovarian cancer.
    PLoS One. 2023;18:e0290031.
    >> Share

  120. NGERNPROM P, Klangsin S, Suwanrath C, Peeyananjarassri K, et al
    Risk factors for recurrent endometriosis after conservative surgery in a quaternary care center in southern Thailand.
    PLoS One. 2023;18:e0289832.
    >> Share

  121. CHONA EZ, Msengi EA, Gosse RA, Ambikile JS, et al
    The lived experiences and caring needs of women diagnosed with cervical cancer: A qualitative study in Dar es Salaam, Tanzania.
    PLoS One. 2023;18:e0289925.
    >> Share

  122. BANAEI M, Kariman N, Ghasemi V, Roozbeh N, et al
    Component of sexual health services for vaginismus management: A qualitative study.
    PLoS One. 2023;18:e0283732.
    >> Share

  123. OKYERE ASANTE PG, Owusu AY, Oppong JR, Amegah KE, et al
    The psychosocial burden of women seeking treatment for breast and cervical cancers in Ghana's major cancer hospitals.
    PLoS One. 2023;18:e0289055.
    >> Share

  124. GONG M, Shen F, Li Y, Ming L, et al
    MLK4 as an immune marker and its correlation with immune infiltration in Cervical squamous cell carcinoma and endocervical adenocarcinoma(CESC).
    PLoS One. 2023;18:e0290462.
    >> Share

  125. ODEH HI, Al-Badi SR, Karima B, Saeed TA, et al
    Exploring the prevalence of Human Papillomavirus (HPV) genotypes in PAP smear samples of women in northern region of United Arab Emirates (UAE): HPV Direct Flow CHIP system-based pilot study.
    PLoS One. 2023;18:e0286889.
    >> Share

  126. URQUHART G, Maclennan SJ, Guntupalli AM
    Is there an association between intimate partner violence and the prevalence of cervical cancer screening in Jordan?
    PLoS One. 2023;18:e0290678.
    >> Share

  127. XU X, Chen L, Nunez-Smith M, Clark M, et al
    Timeliness of diagnostic evaluation for postmenopausal bleeding: A retrospective cohort study using claims data.
    PLoS One. 2023;18:e0289692.
    >> Share

  128. SUNDARA RAJAN R S, Thomas J, Francis D, Daniel EC, et al
    Effective gene delivery using size dependant nano core-shell in human cervical cancer cell lines by magnetofection.
    PLoS One. 2023;18:e0289731.
    >> Share

  129. WANG S, Wang Y, Zhuang J, Wu Y, et al
    Prognostic significance of index (LANR) composed of preoperative lymphocytes, albumin, and neutrophils in patients with stage IB-IIA cervical cancer.
    PLoS One. 2023;18:e0290905.
    >> Share

  130. MOATAMED NA, Vahdatshariatpanahi S, Gjertson DW, Sachs CR, et al
    Androgen receptor and its correlation with estrogen and progesterone receptors, aimed for identification of cases for future anti-androgen therapy in endometrial cancers.
    PLoS One. 2023;18:e0291361.
    >> Share

  131. TOMITA T, Toda M, Kaneko A, Murakumo K, et al
    Successful delivery of viviparous lantern shark from an artificial uterus and the self-production of lantern shark luciferin.
    PLoS One. 2023;18:e0291224.
    >> Share

  132. IORDANISHVILI S, Metreveli T, Lipartia E, Gachechiladze K, et al
    The HPV-TP53-MALAT1 Axis: Unravelling interactions in cervical cancer development.
    PLoS One. 2023;18:e0291725.
    >> Share

  133. FIGHERA TM, Dos Santos BR, Spritzer PM
    Lean mass and associated factors in women with PCOS with different phenotypes.
    PLoS One. 2023;18:e0292623.
    >> Share

  134. MANTULA F, Toefy Y
    Women and health providers' perspectives on male support for cervical cancer screening in Gwanda district, Zimbabwe.
    PLoS One. 2023;18:e0282931.
    >> Share

  135. FERREIRA HNC, Capistrano GN, Morais TNB, Costa KTDS, et al
    Screening and hospitalization of breast and cervical cancer in Brazil from 2010 to 2022: A time-series study.
    PLoS One. 2023;18:e0278011.
    >> Share

  136. LIU S, Zhao X, Meng Q, Li B, et al
    Screening of potential biomarkers for polycystic ovary syndrome and identification of expression and immune characteristics.
    PLoS One. 2023;18:e0293447.
    >> Share

  137. QAQISH A, Abdo N, Abbas MM, Saadeh N, et al
    Awareness and knowledge of physicians and residents on the non-sexual routes of human papilloma virus (HPV) infection and their perspectives on anti-HPV vaccination in Jordan.
    PLoS One. 2023;18:e0291643.
    >> Share

  138. LEE S, Lee SY, Lee W
    Occupational characteristics and risk factors associated with endometriosis among Korean female workers.
    PLoS One. 2023;18:e0292362.
    >> Share

  139. MUHAMMAD S, Azwan RJ, Rita RS, Susanti R, et al
    The Role of Interleukin 6 (IL6), Cancer Antigen-125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients.
    PLoS One. 2023;18:e0292282.
    >> Share

  140. GIRARD E, Mazloum A, Navarria-Forney I, Pluchino N, et al
    Women's lived experience of endometriosis-related fertility issues.
    PLoS One. 2023;18:e0293531.
    >> Share

  141. ZHAO X, Gopalappa C
    Joint modeling HIV and HPV using a new hybrid agent-based network and compartmental simulation technique.
    PLoS One. 2023;18:e0288141.
    >> Share

  142. TACHIWENYIKA E, Dhodho M, Muchedzi A, Sibanda TP, et al
    Prevalence of Cervical Cancer and Clinical Management of Women Screened positive using visual inspection with acetic acid and Cervicography in selected public sector health facilities of Manicaland and Midlands provinces of Zimbabwe, 2021.
    PLoS One. 2023;18:e0294115.
    >> Share

  143. XU X, Yang A, Han Y, Wang W, et al
    The association between serum prolactin levels and live birth rates in non-PCOS patients: A retrospective cohort study.
    PLoS One. 2023;18:e0295071.
    >> Share

  144. LEE B, Chang SJ, Kwon BS, Son JH, et al
    Impact of PARP inhibitor maintenance therapy in newly diagnosed advanced epithelial ovarian cancer: A meta-analysis.
    PLoS One. 2023;18:e0294647.
    >> Share

  145. ROBERTSON SE, Yasukawa M, Marchion DC, Xiong Y, et al
    Prevalence of viral DNA in high-grade serous epithelial ovarian cancer and correlation with clinical outcomes.
    PLoS One. 2023;18:e0294448.
    >> Share

  146. ASSEFA EM, Chane G, Teme A, Nigatu TA, et al
    Determinants of prelabor rupture of membrane among pregnant women attending governmental hospitals in Jimma zone, Oromia region, Ethiopia: A multi-center case-control study.
    PLoS One. 2023;18:e0294482.
    >> Share

  147. LEE HS, Lim YC, Kim DI, Park KS, et al
    Comparative analysis of infertility healthcare utilization before and after insurance coverage of assisted reproductive technology: A cross-sectional study using National Patient Sample data.
    PLoS One. 2023;18:e0294903.
    >> Share

  148. QULU W, Mtshali A, Osman F, Ndlela N, et al
    High-risk human papillomavirus prevalence among South African women diagnosed with other STIs and BV.
    PLoS One. 2023;18:e0294698.
    >> Share

  149. KE J, Feng Y, Chen Z
    Association between waist circumference and female infertility in the United States.
    PLoS One. 2023;18:e0295360.
    >> Share

  150. ALMASOUDI HH, Nahari MH, Alhazmi AYM, Almasabi SHA, et al
    Delineating Pixantrone Maleate's adroit activity against cervical cancer proteins through multitargeted docking-based MM\GBSA, QM-DFT and MD simulation.
    PLoS One. 2023;18:e0295714.
    >> Share

  151. RAZZAK MA, Islam MN, Aadeeb MS, Tasnim T, et al
    Digital health interventions for cervical cancer care: A systematic review and future research opportunities.
    PLoS One. 2023;18:e0296015.
    >> Share

  152. AL-OSEELY S, Abdul Manaf R, Ismail S
    Factors affecting cervical cancer screening among Yemeni immigrant women in Klang Valley, Malaysia: A cross sectional study.
    PLoS One. 2023;18:e0290152.
    >> Share

  153. GIANFALDONI A, Roa C, Dos Santos Simoes R, Baracat MCP, et al
    Association of intrauterine synechiae with pituitary gonadotrophin pulse patterns: A pilot study.
    PLoS One. 2023;18:e0289075.
    >> Share

  154. GEBREMESKEL TG, Gebretatios MZ
    Determinants of cervical cancer screening utilization among HIV-positive women, in public general hospitals of Central Zone, Tigray, Ethiopia, 2020: Case-control study.
    PLoS One. 2023;18:e0289042.
    >> Share

  155. LONKY NM, Chiu V, Portugal C, Estrada EL, et al
    Adenomyosis in women undergoing hysterectomy for abnormal uterine bleeding associated with uterine leiomyomas.
    PLoS One. 2023;18:e0294925.
    >> Share

  156. NOVAIS IR, Coelho CO, Machado HC, Surita F, et al
    Cervical cancer screening in Brazilian Amazon Indigenous women: Towards the intensification of public policies for prevention.
    PLoS One. 2023;18:e0294956.
    >> Share

  157. TOSADO-RODRIGUEZ E, Mendez LB, Espino AM, Dorta-Estremera S, et al
    Inflammatory cytokines and a diverse cervicovaginal microbiota associate with cervical dysplasia in a cohort of Hispanics living in Puerto Rico.
    PLoS One. 2023;18:e0284673.
    >> Share

  158. ZUCON BACELAR AC, Momesso NR, Pederro FHM, Goncalves A, et al
    Aged and induced-premature ovarian failure mouse models affect diestrus profile and ovarian features.
    PLoS One. 2023;18:e0284887.
    >> Share

  159. NELSON K, Shirin S, Kalidasan D, Prior JC, et al
    Experiences of women living with Polycystic Ovary Syndrome: A pilot case-control, single-cycle, daily Menstrual Cycle Diary study during the SARS-CoV-2 pandemic.
    PLoS One. 2023;18:e0296377.
    >> Share

  160. JOTHI R, Hong ST, Enkhtsatsral M, Pandian SK, et al
    ROS mediated anticandidal efficacy of 3-Bromopyruvate prevents vulvovaginal candidiasis in mice model.
    PLoS One. 2023;18:e0295922.
    >> Share

    January 2022
  161. SENGUPTA D, Ali SN, Bhattacharya A, Mustafi J, et al
    A deep hybrid learning pipeline for accurate diagnosis of ovarian cancer based on nuclear morphology.
    PLoS One. 2022;17:e0261181.
    >> Share

  162. RUDD ML, Hansen NF, Zhang X, Urick ME, et al
    KLF3 and PAX6 are candidate driver genes in late-stage, MSI-hypermutated endometrioid endometrial carcinomas.
    PLoS One. 2022;17:e0251286.
    >> Share

  163. GONZALEZ A, Sanchez R, Camargo M, Soto-De Leon SC, et al
    Cervical cancer screening programme attendance and compliance predictors regarding Colombia's Amazon region.
    PLoS One. 2022;17:e0262069.
    >> Share

  164. WANG Y, Zhao S, Qin Q, Gao X, et al
    CKMT1A is a novel potential prognostic biomarker in patients with endometrial cancer.
    PLoS One. 2022;17:e0262000.
    >> Share

  165. BRUGGMANN D, Quinkert-Schmolke K, Jaque JM, Quarcoo D, et al
    Global cervical cancer research: A scientometric density equalizing mapping and socioeconomic analysis.
    PLoS One. 2022;17:e0261503.
    >> Share

  166. KORN AK, Muzingwani L, O'Bryan G, Ensminger A, et al
    Cervical cancer screening and treatment, HIV infection, and age: Program implementation in seven regions of Namibia.
    PLoS One. 2022;17:e0263920.
    >> Share

  167. KUNASETH J, Waiyaput W, Chanchaem P, Sawaswong V, et al
    Vaginal microbiome of women with adenomyosis: A case-control study.
    PLoS One. 2022;17:e0263283.
    >> Share

  168. BULA AK, Lee F, Chapola J, Mapanje C, et al
    Perceptions of cervical cancer and motivation for screening among women in Rural Lilongwe, Malawi: A qualitative study.
    PLoS One. 2022;17:e0262590.
    >> Share

  169. SADEGHI H, Braun HS, Panti B, Opsomer G, et al
    Validation of a deep learning-based image analysis system to diagnose subclinical endometritis in dairy cows.
    PLoS One. 2022;17:e0263409.
    >> Share

  170. GRINDHEIM S, Ebbing C, Karlsen HO, Skulstad SM, et al
    Metformin exposure, maternal PCOS status and fetal venous liver circulation: A randomized, placebo-controlled study.
    PLoS One. 2022;17:e0262987.
    >> Share

  171. LEWIS S, Mphande M, Chibwana F, Gumbo T, et al
    Association of HIV status and treatment characteristics with VIA screening outcomes in Malawi: A retrospective analysis.
    PLoS One. 2022;17:e0262904.
    >> Share

  172. KELLER EJ, Nixon K, Oladini L, Chrisman HB, et al
    The power of proximity: Effects of a multidisciplinary fibroid clinic on inter-specialty perceptions and practice patterns.
    PLoS One. 2022;17:e0263058.
    >> Share

  173. CYR MP, Dostie R, Camden C, Dumoulin C, et al
    Improvements following multimodal pelvic floor physical therapy in gynecological cancer survivors suffering from pain during sexual intercourse: Results from a one-year follow-up mixed-method study.
    PLoS One. 2022;17:e0262844.
    >> Share

  174. BADACHO AS, Lelu MA, Gelan Z, Woltamo DD, et al
    Uterine prolapse and associated factors among reproductive-age women in south-west Ethiopia: A community-based cross-sectional study.
    PLoS One. 2022;17:e0262077.
    >> Share

  175. MIYAJI KT, Infante V, Picone CM, Levi JE, et al
    Human Papillomavirus (HPV) seroprevalence, cervical HPV prevalence, genotype distribution and cytological lesions in solid organ transplant recipients and immunocompetent women in Sao Paulo, Brazil.
    PLoS One. 2022;17:e0262724.
    >> Share

  176. DEMISSIE BW, Azeze GA, Asseffa NA, Lake EA, et al
    Communities' perceptions towards cervical cancer and its screening in Wolaita zone, southern Ethiopia: A qualitative study.
    PLoS One. 2022;17:e0262142.
    >> Share

  177. LIA M, Horn LC, Sodeikat P, Hockel M, et al
    The diagnostic value of core needle biopsy in cervical cancer: A retrospective analysis.
    PLoS One. 2022;17:e0262257.
    >> Share

  178. MCBRIDE CM, Campbell GP, Zhao J, Pentz RD, et al
    Applying citizen science to engage families affected by ovarian cancer in developing genetic service outreach strategies.
    PLoS One. 2022;17:e0262575.
    >> Share

  179. JUMAAH AS, Al-Haddad HS, McAllister KA, Yasseen AA, et al
    The clinicopathology and survival characteristics of patients with POLE proofreading mutations in endometrial carcinoma: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0263585.
    >> Share

  180. OMENAI SA, Ajani MA, Okolo CA
    Programme death ligand 1 expressions as a surrogate for determining immunotherapy in cervical carcinoma patients.
    PLoS One. 2022;17:e0263615.
    >> Share

  181. HONG S, Park KH, Lee YE, Lee JE, et al
    Antibody microarray analysis of amniotic fluid proteomes in women with cervical insufficiency and short cervix, and their association with pregnancy latency length.
    PLoS One. 2022;17:e0263586.
    >> Share

  182. WU Y, Zhu Y, Xie N, Wang H, et al
    A network pharmacology approach to explore active compounds and pharmacological mechanisms of a patented Chinese herbal medicine in the treatment of endometriosis.
    PLoS One. 2022;17:e0263614.
    >> Share

  183. SAGLAM O, Cao B, Wang X, Toruner GA, et al
    Expression of epigenetic pathway related genes in association with PD-L1, ER/PgR and MLH1 in endometrial carcinoma.
    PLoS One. 2022;17:e0264014.
    >> Share

  184. DE JONG KA, Berisha F, Naderpoor N, Appelbe A, et al
    Polycystic ovarian syndrome increases prevalence of concentric hypertrophy in normotensive obese women.
    PLoS One. 2022;17:e0263312.
    >> Share

  185. YALEW GT, Muthupandian S, Hagos K, Negash L, et al
    Prevalence of bacterial vaginosis and aerobic vaginitis and their associated risk factors among pregnant women from northern Ethiopia: A cross-sectional study.
    PLoS One. 2022;17:e0262692.
    >> Share

  186. GAYATRI M, Utomo B, Budiharsana M, Dasvarma G, et al
    Pregnancy resumption following contraceptive discontinuation: Hazard survival analysis of the Indonesia Demographic and Health Survey Data 2007, 2012 and 2017.
    PLoS One. 2022;17:e0264318.
    >> Share

  187. SEIFU B, Fikru C, Yilma D, Tessema F, et al
    Predictors of time to death among cervical cancer patients at Tikur Anbesa specialized hospital from 2014 to 2019: A survival analysis.
    PLoS One. 2022;17:e0264369.
    >> Share

  188. MBAH CE, Jasani A, Aaron KJ, Akoachere JF, et al
    Association between Chlamydia trachomatis, Neisseria gonorrhea, Mycoplasma genitalium, and Trichomonas vaginalis and Secondary Infertility in Cameroon: A case-control study.
    PLoS One. 2022;17:e0263186.
    >> Share

  189. PRIP CM, Stentebjerg M, Bennetsen MH, Petersen LK, et al
    Risk of atypical hyperplasia and endometrial carcinoma after initial diagnosis of non-atypical endometrial hyperplasia: A long-term follow-up study.
    PLoS One. 2022;17:e0266339.
    >> Share

  190. ABRAR S, Abrar T, Sayyed E, Naqvi SA, et al
    Ruptured uterus: Frequency, risk factors and feto-maternal outcome: Current scenario in a low-resource setup.
    PLoS One. 2022;17:e0266062.
    >> Share

  191. PETROCCHI S, Ongaro G, Calvello M, Feroce I, et al
    A randomized controlled trial comparing self-referred message to family-referred message promoting men's adherence to evidence-based guidelines on BRCA1/2 germline genetic testing: A registered study protocol.
    PLoS One. 2022;17:e0266327.
    >> Share

  192. YACOUTI A, Elkhoudri N, El Got A, Benider A, et al
    Awareness, attitudes and acceptability of the HPV vaccine among female university students in Morocco.
    PLoS One. 2022;17:e0266081.
    >> Share

  193. PHAIPHICHIT J, Paboriboune P, Kunnavong S, Chanthavilay P, et al
    Factors associated with cervical cancer screening among women aged 25-60 years in Lao People's Democratic Republic.
    PLoS One. 2022;17:e0266592.
    >> Share

  194. HUANG Y, Yin X, Wang X, Zhou F, et al
    Is a single dose of commonly used antibiotics effective in preventing maternal infection after cesarean section? A network meta-analysis.
    PLoS One. 2022;17:e0264438.
    >> Share

  195. SAKAMOTO J, Saito M, Zhang S, Takakura M, et al
    Determination of human papillomavirus type in archival tissue specimens of invasive cervical cancer using molecular mapping and E6/E7-based polymerase chain reaction.
    PLoS One. 2022;17:e0265996.
    >> Share

  196. GHAZEERI G, Ibrahim N, Khalifeh F, Beyrouthy C, et al
    Character strengths of women with polycystic ovary syndrome in a single center.
    PLoS One. 2022;17:e0266398.
    >> Share

  197. DICKSON MJ, Bishop JV, Hansen TR, Sheldon IM, et al
    The endometrial transcriptomic response to pregnancy is altered in cows after uterine infection.
    PLoS One. 2022;17:e0265062.
    >> Share

  198. ROJAS ROJAS T, Poizot-Martin I, Rey D, Duvivier C, et al
    Incidence of cervical, breast and colorectal cancers between 2010 and 2015 in people living with HIV in France.
    PLoS One. 2022;17:e0261069.
    >> Share

  199. CHAW L, Lee SHF, Ja'afar NIH, Lim E, et al
    Reasons for non-attendance to cervical cancer screening and acceptability of HPV self-sampling among Bruneian women: A cross-sectional study.
    PLoS One. 2022;17:e0262213.
    >> Share

  200. LI K, Wei H, He X, Tian Z, et al
    Relational POI recommendation model combined with geographic information.
    PLoS One. 2022;17:e0266340.
    >> Share

  201. D S P, Chaturvedi PK, Krishnamoorthy D, Seo YS, et al
    Fused toes homolog, a potential molecular regulator of human papillomavirus type 16 E6 and E7 oncoproteins in cervical cancer.
    PLoS One. 2022;17:e0266532.
    >> Share

  202. TEKALIGN T, Teshome M
    Prevalence and determinants of late-stage presentation among cervical cancer patients, a systematic review and meta-analysis.
    PLoS One. 2022;17:e0267571.
    >> Share

  203. ELHASSANNY AEM, Abutaleb NS, Seleem MN
    Auranofin exerts antibacterial activity against Neisseria gonorrhoeae in a female mouse model of genital tract infection.
    PLoS One. 2022;17:e0266764.
    >> Share

  204. SUO M, Lin Z, Guo D, Zhang A, et al
    Hsa_circ_0056686, derived from cancer-associated fibroblasts, promotes cell proliferation and suppresses apoptosis in uterine leiomyoma through inhibiting endoplasmic reticulum stress.
    PLoS One. 2022;17:e0266374.
    >> Share

  205. ELIES A, Bonneau C, Houzard S, Rouzier R, et al
    Impact of catch-up human papillomavirus vaccination on cervical conization rate in a real-life population in France.
    PLoS One. 2022;17:e0264821.
    >> Share

  206. MBULAWA ZZA, Phohlo K, Garcia-Jardon M, Williamson AL, et al
    High human papillomavirus (HPV)-35 prevalence among South African women with cervical intraepithelial neoplasia warrants attention.
    PLoS One. 2022;17:e0264498.
    >> Share

  207. CHAINARONG N, Deevongkij K, Petpichetchian C
    Secondary postpartum hemorrhage: Incidence, etiologies, and clinical courses in the setting of a high cesarean delivery rate.
    PLoS One. 2022;17:e0264583.
    >> Share

  208. DENG ZM, Chen GH, Dai FF, Liu SY, et al
    The clinical value of miRNA-21 in cervical cancer: A comprehensive investigation based on microarray datasets.
    PLoS One. 2022;17:e0267108.
    >> Share

  209. BENEDICT K, Lyman M, Jackson BR
    Possible misdiagnosis, inappropriate empiric treatment, and opportunities for increased diagnostic testing for patients with vulvovaginal candidiasis-United States, 2018.
    PLoS One. 2022;17:e0267866.
    >> Share

  210. ZENG J, Sun P, Ping Q, Jiang S, et al
    Clinical outcome of FIGO 2018 stage IB3/IIA2 cervical cancer treated by neoadjuvant chemotherapy followed by radical surgery due to lack of radiotherapy equipment: A retrospective comparison with concurrent chemoradiotherapy.
    PLoS One. 2022;17:e0266001.
    >> Share

  211. ELSHAMI M, Tuffaha A, Yaseen A, Alser M, et al
    Awareness of ovarian cancer risk and protective factors: A national cross-sectional study from Palestine.
    PLoS One. 2022;17:e0265452.
    >> Share

  212. ANNONI AM, Longhini C
    Investigating men's motivations to engage in genetic screening for BRCA1 and BRCA2 mutations.
    PLoS One. 2022;17:e0265387.
    >> Share

  213. SALARIA D, Rolta R, Mehta J, Awofisayo O, et al
    Phytoconstituents of traditional Himalayan Herbs as potential inhibitors of Human Papillomavirus (HPV-18) for cervical cancer treatment: An In silico Approach.
    PLoS One. 2022;17:e0265420.
    >> Share

  214. TAYLOR MM, Wi T, Gerbase A, Thwin SS, et al
    Assessment of country implementation of the WHO global health sector strategy on sexually transmitted infections (2016-2021).
    PLoS One. 2022;17:e0263550.
    >> Share

  215. DUFEIL E, Kenfack B, Tincho E, Fouogue J, et al
    Addition of digital VIA/VILI to conventional naked-eye examination for triage of HPV-positive women: A study conducted in a low-resource setting.
    PLoS One. 2022;17:e0268015.
    >> Share

  216. WINARTO H, Habiburrahman M, Dorothea M, Wijaya A, et al
    Knowledge, attitudes, and practices among Indonesian urban communities regarding HPV infection, cervical cancer, and HPV vaccination.
    PLoS One. 2022;17:e0266139.
    >> Share

  217. GARCIA DE ARRIBA S, Gruntkemeier L, Hauser M, May TW, et al
    Vaginal hormone-free moisturising cream is not inferior to an estriol cream for treating symptoms of vulvovaginal atrophy: Prospective, randomised study.
    PLoS One. 2022;17:e0266633.
    >> Share

  218. OCHI T, Kurihara M, Tsuboshima K, Nonaka Y, et al
    Dynamics of thoracic endometriosis in the pleural cavity.
    PLoS One. 2022;17:e0268299.
    >> Share

  219. CHANGKUN Z, Bishwajit G, Ji L, Tang S, et al
    Sociodemographic correlates of cervix, breast and oral cancer screening among Indian women.
    PLoS One. 2022;17:e0265881.
    >> Share

  220. LEE KN, Park KH, Kim YM, Cho I, et al
    Prediction of emergency cerclage outcomes in women with cervical insufficiency: The role of inflammatory, angiogenic, and extracellular matrix-related proteins in amniotic fluid.
    PLoS One. 2022;17:e0268291.
    >> Share

  221. NIE C, Qin H, Zhang L
    Identification and validation of a prognostic signature related to hypoxic tumor microenvironment in cervical cancer.
    PLoS One. 2022;17:e0269462.
    >> Share

  222. AMO-ANTWI K, Agambire R, Konney TO, Nguah SB, et al
    Health-related quality of life among cervical cancer survivors at a tertiary hospital in Ghana.
    PLoS One. 2022;17:e0268831.
    >> Share

  223. SHAFRIR AL, Vitonis AF, Wallace B, DiVasta AD, et al
    Cohort profile: The Endometriosis pain QUality aftEr Surgical Treatment (EndoQUEST) Study.
    PLoS One. 2022;17:e0269858.
    >> Share

  224. DING Y, Oliveira-Ferrer L, Vettorazzi E, Legler K, et al
    VEGF-C serum level is associated with response to bevacizumab maintenance therapy in primary ovarian cancer patients.
    PLoS One. 2022;17:e0269680.
    >> Share

  225. DE SILVA K, Demmer RT, Jonsson D, Mousa A, et al
    Causality of anthropometric markers associated with polycystic ovarian syndrome: Findings of a Mendelian randomization study.
    PLoS One. 2022;17:e0269191.
    >> Share

  226. RAVEGNINI G, Ferioli M, Pantaleo MA, Morganti AG, et al
    Radiomics and artificial intelligence in malignant uterine body cancers: Protocol for a systematic review.
    PLoS One. 2022;17:e0267727.
    >> Share

  227. TOMIOKA A, Obama K, Okada H, Yamauchi E, et al
    Nurse's perceptions of support for sexual and reproductive issues in adolescents and young adults with cancer.
    PLoS One. 2022;17:e0265830.
    >> Share

  228. HASAN M, Sultana S, Sohan M, Parvin S, et al
    Prevalence and associated risk factors for mental health problems among patients with polycystic ovary syndrome in Bangladesh: A nationwide cross-Sectional study.
    PLoS One. 2022;17:e0270102.
    >> Share

  229. LI Y, Zhi W, Haoxu D, Qing W, et al
    Effects of electroacupuncture on the expression of hypothalamic neuropeptide Y and ghrelin in pubertal rats with polycystic ovary syndrome.
    PLoS One. 2022;17:e0259609.
    >> Share

  230. SEVERGNINI M, Morselli S, Camboni T, Ceccarani C, et al
    Gardnerella vaginalis clades in pregnancy: New insights into the interactions with the vaginal microbiome.
    PLoS One. 2022;17:e0269590.
    >> Share

  231. VATANNEJAD A, Fadaei R, Salimi F, Fouani FZ, et al
    Plasma Complement C1q/tumor necrosis factor-related protein 15 concentration is associated with polycystic ovary syndrome.
    PLoS One. 2022;17:e0263658.
    >> Share

  232. SRIPAN P, Pongnikorn D, Chitapanarux I, Tangmunkongvorakul A, et al
    Geographical risk pattern and temporal trends in incidence of HPV-related cancers in northern Thailand: A population-based study.
    PLoS One. 2022;17:e0270670.
    >> Share

  233. MEBRATIE AE, Moges NA, Meselu BT, Melesse MF, et al
    Time to death from cervical cancer and predictors among cervical cancer patients in Felege Hiwot Comprehensive Specialized Hospital, North West Ethiopia: Facility-based retrospective follow-up study.
    PLoS One. 2022;17:e0269576.
    >> Share

  234. MEIERHOFER R, Tomberge VMJ, Inauen J, Shrestha A, et al
    Water carrying in hills of Nepal-associations with women's musculoskeletal disorders, uterine prolapse, and spontaneous abortions.
    PLoS One. 2022;17:e0269926.
    >> Share

  235. OMAR IS, Abd Jamil AH, Mat Adenan NA, Chung I, et al
    MPA alters metabolic phenotype of endometrial cancer-associated fibroblasts from obese women via IRS2 signaling.
    PLoS One. 2022;17:e0270830.
    >> Share

  236. EL MANSOURI N, Ferrera L, Kharbach A, Achbani A, et al
    Awareness and knowledge associated to Human papillomavirus infection among university students in Morocco: A cross-sectional study.
    PLoS One. 2022;17:e0271222.
    >> Share

  237. THONGRUEANG N, Liu SS, Hsu HY, Lee HH, et al
    An in vitro comparison of antimicrobial efficacy and cytotoxicity between povidone-iodine and chlorhexidine for treating clinical endometritis in dairy cows.
    PLoS One. 2022;17:e0271274.
    >> Share

  238. HAZAMA Y, Tsujioka T, Kitanaka A, Tohyama K, et al
    Histone deacetylase inhibitor, panobinostat, exerts anti-proliferative effect with partial normalization from aberrant epigenetic states on granulosa cell tumor cell lines.
    PLoS One. 2022;17:e0271245.
    >> Share

  239. KIM M, Kim J, Park NJ, Park JY, et al
    Comparison of Seegene Anyplex II HPV28 assay with BD Onclarity HPV assay for human papillomavirus genotyping.
    PLoS One. 2022;17:e0267836.
    >> Share

  240. SHUMIE ZS, Mengie ZA
    Menstrual hygiene management knowledge, practice and associated factors Among School Girls, Northeast Ethiopia.
    PLoS One. 2022;17:e0271275.
    >> Share

  241. YANG Z, Liu J, Wang Q
    Diagnose earlier, live longer? The impact of cervical and breast cancer screening on life span.
    PLoS One. 2022;17:e0270347.
    >> Share

  242. SHIMELS T, Gashaw B, Gedif T
    Association between delayed initiation of treatment indications and survival in patients with cervical cancer: A systematic review and meta-analysis protocol.
    PLoS One. 2022;17:e0271604.
    >> Share

  243. MIAO C, Chen Y, Fang X, Zhao Y, et al
    Identification of the shared gene signatures and pathways between polycystic ovary syndrome and endometrial cancer: An omics data based combined approach.
    PLoS One. 2022;17:e0271380.
    >> Share

  244. LEMMA D, Aboma M, Girma T, Dechesa A, et al
    Determinants of utilization of cervical cancer screening among women in the age group of 30-49 years in Ambo Town, Central Ethiopia: A case-control study.
    PLoS One. 2022;17:e0270821.
    >> Share

  245. BEYEN MW, Bulto GA, Chaka EE, Debelo BT, et al
    Human papillomavirus vaccination uptake and its associated factors among adolescent school girls in Ambo town, Oromia region, Ethiopia, 2020.
    PLoS One. 2022;17:e0271237.
    >> Share

  246. OLANIYI KS, Bashir AM, Areloegbe SE, Sabinari IW, et al
    Short chain fatty acid, acetate restores ovarian function in experimentally induced PCOS rat model.
    PLoS One. 2022;17:e0272124.
    >> Share

  247. DANSONKA-MIESZKOWSKA A, Szafron LA, Kulesza M, Stachurska A, et al
    PROM1, CXCL8, RUNX1, NAV1 and TP73 genes as independent markers predictive of prognosis or response to treatment in two cohorts of high-grade serous ovarian cancer patients.
    PLoS One. 2022;17:e0271539.
    >> Share

  248. BARRERA FERRO D, Bayer S, Bocanegra L, Brailsford S, et al
    Understanding no-show behaviour for cervical cancer screening appointments among hard-to-reach women in Bogota, Colombia: A mixed-methods approach.
    PLoS One. 2022;17:e0271874.
    >> Share

  249. AYANTO SY, Belachew T, Wordofa MA
    Effectiveness of couple education and counseling on knowledge, attitude and uptake of cervical cancer screening service among women of child bearing age in Southern Ethiopia: A cluster randomized trial protocol.
    PLoS One. 2022;17:e0270663.
    >> Share

  250. TERBLANCHE L, Botha MH
    Uterine carcinosarcoma: A 10-year single institution experience.
    PLoS One. 2022;17:e0271526.
    >> Share

  251. ALI FT, Soliman RM, Hassan NS, Ibrahim AM, et al
    Sensitivity and specificity of microRNA-204, CA125, and CA19.9 as biomarkers for diagnosis of ovarian cancer.
    PLoS One. 2022;17:e0272308.
    >> Share

  252. OTTOLINA J, Vignali M, Papaleo E, Vigano P, et al
    Surgery versus IVF for the treatment of infertility associated to ovarian and deep endometriosis (SVIDOE: Surgery Versus IVF for Deep and Ovarian Endometriosis). Clinical protocol for a multicenter randomized controlled trial.
    PLoS One. 2022;17:e0271173.
    >> Share

  253. SRIRAMKUMAR S, Metcalfe TX, Lai T, Zong X, et al
    Single-cell analysis of a high-grade serous ovarian cancer cell line reveals transcriptomic changes and cell subpopulations sensitive to epigenetic combination treatment.
    PLoS One. 2022;17:e0271584.
    >> Share

  254. CORREA RM, Baena A, Valls J, Colucci MC, et al
    Distribution of human papillomavirus genotypes by severity of cervical lesions in HPV screened positive women from the ESTAMPA study in Latin America.
    PLoS One. 2022;17:e0272205.
    >> Share

  255. MOLLIN A, Katta M, Sobel JD, Akins RA, et al
    Association of key species of vaginal bacteria of recurrent bacterial vaginosis patients before and after oral metronidazole therapy with short- and long-term clinical outcomes.
    PLoS One. 2022;17:e0272012.
    >> Share

  256. HIEPP L, Mayr D, Gartner K, Schmoeckel E, et al
    Carbonic anhydrase XII as biomarker and therapeutic target in ovarian carcinomas.
    PLoS One. 2022;17:e0271630.
    >> Share

  257. CHANG CY, Yang L, Tse J, Lo LC, et al
    Genetic variations in UCA1, a lncRNA functioning as a miRNA sponge, determine endometriosis development and the potential associated infertility via regulating lipogenesis.
    PLoS One. 2022;17:e0271616.
    >> Share

  258. GEBRIE A
    Disease progression role as well as the diagnostic and prognostic value of microRNA-21 in patients with cervical cancer: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0268480.
    >> Share

  259. YANG Z, Zhang Y, Stubbe-Espejel A, Zhao Y, et al
    Vaginal microbiota and personal risk factors associated with HPV status conversion-A new approach to reduce the risk of cervical cancer?
    PLoS One. 2022;17:e0270521.
    >> Share

  260. JO A, Joh HM, Bae JH, Kim SJ, et al
    Plasma activated medium prepared by a bipolar microsecond-pulsed atmospheric pressure plasma jet array induces mitochondria-mediated apoptosis in human cervical cancer cells.
    PLoS One. 2022;17:e0272805.
    >> Share

  261. LIU SS, Chan KKL, Wei TN, Tse KY, et al
    Clinical performance of the Roche Cobas 4800 HPV test for primary cervical cancer screening in a Chinese population.
    PLoS One. 2022;17:e0272721.
    >> Share

  262. NJOKU K, Barr CE, Ramchander NC, Crosbie EJ, et al
    Impact of pre-treatment prognostic nutritional index and the haemoglobin, albumin, lymphocyte and platelet (HALP) score on endometrial cancer survival: A prospective database analysis.
    PLoS One. 2022;17:e0272232.
    >> Share

  263. FRIEBEL-KLINGNER TM, Iyer HS, Ramogola-Masire D, Bazzett-Matabele L, et al
    Evaluating the geographic distribution of cervical cancer patients presenting to a multidisciplinary gynecologic oncology clinic in Gaborone, Botswana.
    PLoS One. 2022;17:e0271679.
    >> Share

  264. CAO Z, Xu B, Wu Y, Luan K, et al
    A comprehensive analysis of miRNA/isomiRs profile of hydrosalpinx patients with interventional ultrasound sclerotherapy.
    PLoS One. 2022;17:e0268328.
    >> Share

  265. ROMLI R, Abd Rahman R, Chew KT, Mohd Hashim S, et al
    Empirical investigation of e-health intervention in cervical cancer screening: A systematic literature review.
    PLoS One. 2022;17:e0273375.
    >> Share

  266. KUZNICKI ML, Mallen A, Ha K, McClung EC, et al
    Prognostic features of endometrial cancer metastasis to the central nervous system.
    PLoS One. 2022;17:e0268794.
    >> Share

  267. LUBEYA MK, Mwanahamuntu M, Chibwesha C, Mukosha M, et al
    Implementation strategies to increase human papillomavirus vaccination uptake for adolescent girls in sub-Saharan Africa: A scoping review protocol.
    PLoS One. 2022;17:e0267617.
    >> Share

  268. STERNJAKOB-MARTHALER A, Berko-Gottel B, Rissland J, Schope J, et al
    Human papillomavirus vaccination of girls in the German model region Saarland: Insurance data-based analysis and identification of starting points for improving vaccination rates.
    PLoS One. 2022;17:e0273332.
    >> Share

  269. YOSHIKAWA N, Yoshihara M, Tamauchi S, Ikeda Y, et al
    Hypoalbuminemia for the prediction of survival in patients with stage IVB cervical cancer.
    PLoS One. 2022;17:e0273876.
    >> Share

  270. HOMBAIAH C, Madhu B, Gopi A, Narayana Murthy MR, et al
    Effects of mobile Health (mHealth) application on cervical cancer prevention knowledge and screening among women social support groups with low-socioeconomic status in Mysuru city, Southern India.
    PLoS One. 2022;17:e0273070.
    >> Share

  271. BUTLER TL, Lee N, Anderson K, Brotherton JML, et al
    Under-screened Aboriginal and Torres Strait Islander women's perspectives on cervical screening.
    PLoS One. 2022;17:e0271658.
    >> Share

  272. GALESHI M, Shirafkan H, Yazdani S, Motaghi Z, et al
    Reproductive health needs of Human papillomavirus (HPV) positive women: A systematic review.
    PLoS One. 2022;17:e0266819.
    >> Share

  273. DERBIE A, Amare B, Misgan E, Nibret E, et al
    Histopathological profile of cervical punch biopsies and risk factors associated with high-grade cervical precancerous lesions and cancer in northwest Ethiopia.
    PLoS One. 2022;17:e0274466.
    >> Share

  274. MASEKO B, Bula A, Sasse S, Thom A, et al
    Opinions on integrating couple counselling and female sexual reproductive health services into Voluntary Medical Male Circumcision services in Lilongwe, Malawi.
    PLoS One. 2022;17:e0273627.
    >> Share

  275. ZIBAKO P, Tsikai N, Manyame S, Ginindza TG, et al
    Cervical cancer management in Zimbabwe (2019-2020).
    PLoS One. 2022;17:e0274884.
    >> Share

  276. DAI L, Mugaanyi J, Zhang T, Tong J, et al
    A pan-cancer bioinformatic analysis of the carcinogenic role of SMARCA1 in human carcinomas.
    PLoS One. 2022;17:e0274823.
    >> Share

  277. BITTLESTON H, Hocking JS, Goller JL, Coombe J, et al
    Is there a place for a molecular diagnostic test for pelvic inflammatory disease in primary care? An exploratory qualitative study.
    PLoS One. 2022;17:e0274666.
    >> Share

  278. ABAS BI, Demirbolat GM, Cevik O
    Wharton jelly-derived mesenchymal stem cell exosomes induce apoptosis and suppress EMT signaling in cervical cancer cells as an effective drug carrier system of paclitaxel.
    PLoS One. 2022;17:e0274607.
    >> Share

  279. ISABIRYE A
    Individual and intimate-partner factors associated with cervical cancer screening in Central Uganda.
    PLoS One. 2022;17:e0274602.
    >> Share

  280. KALIFF M, Lillsunde Larsson G, Helenius G, Karlsson MG, et al
    Full genotyping and FAM19A4/miR124-2 methylation analysis in high-risk human papillomavirus-positive samples from women over 30 years participating in cervical cancer screening in Orebro, Sweden.
    PLoS One. 2022;17:e0274825.
    >> Share

  281. LIU Y, Liu Q, Jiang X
    Bibliometric analysis of hotspots and frontiers in cancer-related fatigue among ovarian cancer survivors.
    PLoS One. 2022;17:e0274802.
    >> Share

  282. HEEMSKERK-GERRITSEN BAM, Hollestelle A, van Asperen CJ, van den Beek I, et al
    Progression-free survival and overall survival after BRCA1/2-associated epithelial ovarian cancer: A matched cohort study.
    PLoS One. 2022;17:e0275015.
    >> Share

  283. SCICCHITANO S, Montalcini Y, Lucchino V, Melocchi V, et al
    Enhanced ZNF521 expression induces an aggressive phenotype in human ovarian carcinoma cell lines.
    PLoS One. 2022;17:e0274785.
    >> Share

  284. YESHITILA YG, Daniel B, Desta M, Kassa GM, et al
    Obstructed labor and its effect on adverse maternal and fetal outcomes in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0275400.
    >> Share

  285. THURMAN AR, Brache V, Cochon L, Ouattara LA, et al
    Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women: The CONRAD 138 study.
    PLoS One. 2022;17:e0275794.
    >> Share

  286. DE NARDO MAFFAZIOLI G, Baracat EC, Soares JM, Carvalho KC, et al
    Evaluation of circulating microRNA profiles in Brazilian women with polycystic ovary syndrome: A preliminary study.
    PLoS One. 2022;17:e0275031.
    >> Share

  287. BRONK JK, Kapadia C, Wu X, Chapman BV, et al
    Feasibility of a novel non-invasive swab technique for serial whole-exome sequencing of cervical tumors during chemoradiation therapy.
    PLoS One. 2022;17:e0274457.
    >> Share

  288. ZENO EE, Brewer NT, Spees LP, Des Marais AC, et al
    Racial and ethnic differences in cervical cancer screening barriers and intentions: The My Body My Test-3 HPV self-collection trial among under-screened, low-income women.
    PLoS One. 2022;17:e0274974.
    >> Share

  289. PACHE B, Balaya V, Mathis J, Hubner M, et al
    Prevalence of anal dysplasia and HPV genotypes in gynecology patients: The ANGY cross-sectional prospective clinical study protocol.
    PLoS One. 2022;17:e0276438.
    >> Share

  290. VAN DEN BOSCH AAS, Pijnenborg JMA, Romano A, Haldorsen IS, et al
    The role of fat distribution and inflammation in the origin of endometrial cancer, study protocol of the ENDOCRINE study.
    PLoS One. 2022;17:e0276516.
    >> Share

  291. VEYRIE A, Netter A, Carcopino X, Miquel L, et al
    Endometriosis and pregnancy: The illusion of recovery.
    PLoS One. 2022;17:e0272828.
    >> Share

  292. BASILETTI JA, Valls J, Poklepovich T, Fellner MD, et al
    Human papillomavirus genotyping using next generation sequencing (NGS) in cervical lesions: Genotypes by histologic grade and their relative proportion in multiple infections.
    PLoS One. 2022;17:e0278117.
    >> Share

  293. AL-SHIBLI K, Mohammed HAL, Maurseth R, Fostervold M, et al
    Impact of HPV mRNA types 16, 18, 45 detection on the risk of CIN3+ in young women with normal cervical cytology.
    PLoS One. 2022;17:e0275858.
    >> Share

  294. KELSEY TW, Hua CH, Wyatt A, Indelicato D, et al
    A predictive model of the effect of therapeutic radiation on the human ovary.
    PLoS One. 2022;17:e0277052.
    >> Share

  295. SIM JH, Jang DM, Cho HS, Park JY, et al
    Association of red cell distribution width/albumin ratio with intraoperative blood transfusion in cervical cancer patients.
    PLoS One. 2022;17:e0277481.
    >> Share

  296. PETERSON CE, Dykens JA, Weine SM, Holt HK, et al
    Assessing the interrelationship between stigma, social influence, and cervical cancer prevention in an urban underserved setting: An exploratory study.
    PLoS One. 2022;17:e0278538.
    >> Share

  297. DES MARAIS AC, Brewer NT, Knight S, Smith JS, et al
    Patient perspectives on cervical cancer screening interventions among underscreened women.
    PLoS One. 2022;17:e0277791.
    >> Share

  298. MALKIN J, Allen Scott L, Alberga Machado A, Teare G, et al
    Factors influencing human papillomavirus school-based immunization in Alberta: A mixed-methods study protocol.
    PLoS One. 2022;17:e0278472.
    >> Share

  299. GONZALEZ-BOSQUET J, Weroha SJ, Bakkum-Gamez JN, Weaver AL, et al
    ECPPF (E2F1, CCNA2, POLE, PPP2R1A, FBXW7) stratification: Profiling high-risk subtypes of histomorphologically low-risk and treatment-insensitive endometrioid endometrial cancer.
    PLoS One. 2022;17:e0278408.
    >> Share

  300. DENNINGHOFF V, von Petery F, Fresno C, Galarza M, et al
    Clinical implementation of a cervical cancer screening program via co-testing at a university hospital.
    PLoS One. 2022;17:e0278476.
    >> Share

  301. OLADIPUPO I, Ali T, Hein DW, Pagidas K, et al
    Association between cigarette smoking and ovarian reserve among women seeking fertility care.
    PLoS One. 2022;17:e0278998.
    >> Share

  302. HASHEMI L, Ormsbee ME, Patel PJ, Nielson JA, et al
    A Drosophila model of HPV16-induced cancer reveals conserved disease mechanism.
    PLoS One. 2022;17:e0278058.
    >> Share

  303. DING N, Zhan J, Shi Y, Qiao T, et al
    Obesity in children and adolescents and the risk of ovarian cancer: A systematic review and dose‒response meta-analysis.
    PLoS One. 2022;17:e0278050.
    >> Share

  304. KHOO SP, Muhammad Ridzuan Tan NA, Rajasuriar R, Nasir NH, et al
    Changes in genital Human Papillomavirus (HPV) prevalence among urban females a decade after the Malaysian HPV vaccination program.
    PLoS One. 2022;17:e0278477.
    >> Share

  305. DING H, He C, Tong Y, Fang Q, et al
    Cost-effectiveness of PARP inhibitors in malignancies: A systematic review.
    PLoS One. 2022;17:e0279286.
    >> Share

  306. AMADO G, Weldegebreal F, Birhanu S, Dessie Y, et al
    Cervical cancer screening practices and its associated factors among females of reproductive age in Durame town, Southern Ethiopia.
    PLoS One. 2022;17:e0279870.
    >> Share

  307. BENEDICT K, Moret R, Molinari NAM, Jackson BR, et al
    Survey of healthcare providers' testing practices for vulvovaginal candidiasis and treatment outcomes-United States, 2021.
    PLoS One. 2022;17:e0278630.
    >> Share

    January 2021
  308. VAVALA G, Goldbeck C, Bristow CC, Stafylis C, et al
    Adolescents may accurately self-collect pharyngeal and rectal clinical specimens for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae infection.
    PLoS One. 2021;16:e0255878.
    >> Share

  309. MCGRANAHAN M, Nakyeyune J, Baguma C, Musisi NN, et al
    Rights based approaches to sexual and reproductive health in low and middle-income countries: A systematic review.
    PLoS One. 2021;16:e0250976.
    >> Share

  310. DEV R, Adhikari SP, Dongol A, Madhup SK, et al
    Prevalence assessment of sexually transmitted infections among pregnant women visiting an antenatal care center of Nepal: Pilot of the World Health Organization's standard protocol for conducting STI prevalence surveys among pregnant women.
    PLoS One. 2021;16:e0250361.
    >> Share

  311. CRISPI CP JR, Crispi CP, de Oliveira BRS, de Nadai Filho N, et al
    Six-month follow-up of minimally invasive nerve-sparing complete excision of endometriosis: What about dyspareunia?
    PLoS One. 2021;16:e0250046.
    >> Share

  312. WALL KM, Nyombayire J, Parker R, Ingabire R, et al
    Etiologies of genital inflammation and ulceration in symptomatic Rwandan men and women responding to radio promotions of free screening and treatment services.
    PLoS One. 2021;16:e0250044.
    >> Share

  313. HAHN DL
    Chlamydia pneumoniae and chronic asthma: Updated systematic review and meta-analysis of population attributable risk.
    PLoS One. 2021;16:e0250034.
    >> Share

  314. PEEL E, Cheng Y, Djordjevic JT, O'Meally D, et al
    Koala cathelicidin PhciCath5 has antimicrobial activity, including against Chlamydia pecorum.
    PLoS One. 2021;16:e0249658.
    >> Share

  315. O'SHEA R, Taylor N, Crook A, Jacobs C, et al
    Health system interventions to integrate genetic testing in routine oncology services: A systematic review.
    PLoS One. 2021;16:e0250379.
    >> Share

  316. LLANGARI-ARIZO LM, Sadiq ST, Marquez C, Cooper P, et al
    Sexually transmitted infections and factors associated with risky sexual practices among female sex workers: A cross sectional study in a large Andean city.
    PLoS One. 2021;16:e0250117.
    >> Share

  317. YUK JS, Lee B, Kim K, Kim MH, et al
    Incidence and risk of venous thromboembolism according to primary treatment in women with ovarian cancer: A retrospective cohort study.
    PLoS One. 2021;16:e0250723.
    >> Share

  318. ZHANG L, Hu C, Huang Z, Li Z, et al
    In Silico screening of circulating tumor DNA, circulating microRNAs, and long non-coding RNAs as diagnostic molecular biomarkers in ovarian cancer: A comprehensive meta-analysis.
    PLoS One. 2021;16:e0250717.
    >> Share

  319. RANDALL A, Teng A, Liang X, Pal S, et al
    A primary Chlamydia trachomatis genital infection of rhesus macaques identifies new immunodominant B-cell antigens.
    PLoS One. 2021;16:e0250317.
    >> Share

  320. HO PJ, Yeoh YS, Miao H, Lim SH, et al
    Cohort profile: The Singapore Breast Cancer Cohort (SGBCC), a multi-center breast cancer cohort for evaluation of phenotypic risk factors and genetic markers.
    PLoS One. 2021;16:e0250102.
    >> Share

  321. TAKAHASHI Y, Sone K, Noda K, Yoshida K, et al
    Automated system for diagnosing endometrial cancer by adopting deep-learning technology in hysteroscopy.
    PLoS One. 2021;16:e0248526.
    >> Share

  322. DEVINE A, Vahanian A, Sawadogo B, Zan S, et al
    Costs and cost-effectiveness of cervical cancer screening strategies in women living with HIV in Burkina Faso: The HPV in Africa Research Partnership (HARP) study.
    PLoS One. 2021;16:e0248832.
    >> Share

  323. ZENEBE MH, Mekonnen Z, Loha E, Padalko E, et al
    Prevalence, risk factors and association with delivery outcome of curable sexually transmitted infections among pregnant women in Southern Ethiopia.
    PLoS One. 2021;16:e0248958.
    >> Share

  324. TEMESGEN MM, Alemu T, Shiferaw B, Legesse S, et al
    Prevalence of oncogenic human papillomavirus (HPV 16/18) infection, cervical lesions and its associated factors among women aged 21-49 years in Amhara region, Northern Ethiopia.
    PLoS One. 2021;16:e0248949.
    >> Share

  325. WANG J, Westveld AH, Welsh AH, Parker M, et al
    Analysis of survey on menstrual disorder among teenagers using Gaussian copula model with graphical lasso prior.
    PLoS One. 2021;16:e0248340.
    >> Share

  326. MARCUS U, Mirandola M, Schink SB, Gios L, et al
    Changes in the prevalence of self-reported sexually transmitted bacterial infections from 2010 and 2017 in two large European samples of men having sex with men-is it time to re-evaluate STI-screening as a control strategy?
    PLoS One. 2021;16:e0248582.
    >> Share

  327. DAUBERT E, Weber KM, French AL, Seidman D, et al
    Obesity is associated with lower bacterial vaginosis prevalence in menopausal but not pre-menopausal women in a retrospective analysis of the Women's Interagency HIV Study.
    PLoS One. 2021;16:e0248136.
    >> Share

  328. CHANG CY, Tseng CC, Lai MT, Chiang AJ, et al
    Genetic impacts on thermostability of onco-lncRNA HOTAIR during the development and progression of endometriosis.
    PLoS One. 2021;16:e0248168.
    >> Share

  329. BADRE-ESFAHANI S, Petersen LK, Tatari CR, Blaakaer J, et al
    Perceptions of cervical cancer prevention among a group of ethnic minority women in Denmark-A qualitative study.
    PLoS One. 2021;16:e0250816.
    >> Share

  330. VALE DB, Silva MT, Discacciati MG, Polegatto I, et al
    Is the HPV-test more cost-effective than cytology in cervical cancer screening? An economic analysis from a middle-income country.
    PLoS One. 2021;16:e0251688.
    >> Share

  331. KWON SJ, Im YM
    Sexual health knowledge and needs among young adults with congenital heart disease.
    PLoS One. 2021;16:e0251155.
    >> Share

  332. ZHAI J, Wang L, Qiao X, Zhao J, et al
    Detection of Neisseria gonorrhoeae and Chlamydia trachomatis infections in pregnant women by multiplex recombinase polymerase amplification.
    PLoS One. 2021;16:e0251119.
    >> Share

  333. JONGEN VW, Schim van der Loeff MF, Botha MH, Sudenga SL, et al
    Incidence and risk factors of C. trachomatis and N. gonorrhoeae among young women from the Western Cape, South Africa: The EVRI study.
    PLoS One. 2021;16:e0250871.
    >> Share

  334. MREMI A, Yahaya JJ, Nyindo M, Mollel E, et al
    Transfusion-Transmitted Infections and associated risk factors at the Northern Zone Blood Transfusion Center in Tanzania: A study of blood donors between 2017 and 2019.
    PLoS One. 2021;16:e0249061.
    >> Share

  335. LANGE C, Machado Weber A, Schmidt R, Schroeder C, et al
    Changes in protein expression due to metformin treatment and hyperinsulinemia in a human endometrial cancer cell line.
    PLoS One. 2021;16:e0248103.
    >> Share

  336. OYAMA Y, Shigeta S, Tokunaga H, Tsuji K, et al
    CHD4 regulates platinum sensitivity through MDR1 expression in ovarian cancer: A potential role of CHD4 inhibition as a combination therapy with platinum agents.
    PLoS One. 2021;16:e0251079.
    >> Share

  337. BARCA J, Meikle A, Bouman M, Gnemmi G, et al
    Effect of pegbovigrastim on clinical mastitis and uterine disease during a full lactation in grazing dairy cows.
    PLoS One. 2021;16:e0252418.
    >> Share

  338. OKAFOR OC, Ezemba N, Onyishi NT, Ezike KN, et al
    Improving the diagnostic recognition of thoracic endometriosis: Spotlight on a new histo-morphological indicator.
    PLoS One. 2021;16:e0251385.
    >> Share

  339. BROWN NB, Peragine D, VanderLaan DP, Kingstone A, et al
    Cognitive processing of sexual cues in asexual individuals and heterosexual women with desire/arousal difficulties.
    PLoS One. 2021;16:e0251074.
    >> Share

  340. BAILLEUL A, Niro J, Du Cheyron J, Panel P, et al
    Infertility management according to the Endometriosis Fertility Index in patients operated for endometriosis: What is the optimal time frame?
    PLoS One. 2021;16:e0251372.
    >> Share

  341. FILARDO S, Di Pietro M, Pasqualetti P, Manera M, et al
    In-cell western assay as a high-throughput approach for Chlamydia trachomatis quantification and susceptibility testing to antimicrobials.
    PLoS One. 2021;16:e0251075.
    >> Share

  342. HOPKINS KL, Jaffer M, Hlongwane KE, Otwombe K, et al
    Assessing national cervical cancer screening guidelines: Results from an HIV testing clinic also screening for cervical cancer and HPV in Soweto, South Africa.
    PLoS One. 2021;16:e0255124.
    >> Share

  343. LOPACINSKA-JORGENSEN J, Oliveira DVNP, Wayne Novotny G, Hogdall CK, et al
    Integrated microRNA and mRNA signatures associated with overall survival in epithelial ovarian cancer.
    PLoS One. 2021;16:e0255142.
    >> Share

  344. FOUGNER SL, Vanky E, Lovvik TS, Carlsen SM, et al
    No impact of gestational diabetes mellitus on pregnancy complications in women with PCOS, regardless of GDM criteria used.
    PLoS One. 2021;16:e0254895.
    >> Share

  345. GUI T, Chen Z, Chen F
    Validation of the indication for colposcopy proposed by the 2019 ASCCP risk-based management consensus guidelines: A single-center study in China.
    PLoS One. 2021;16:e0253493.
    >> Share

  346. LI Y, Kong Q, Wei H, Wang Y, et al
    Comparison of the complications between minimally invasive surgery and open surgical treatments for early-stage cervical cancer: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0253143.
    >> Share

  347. FARFOUR E, Dimi S, Chassany O, Fouere S, et al
    Trends in asymptomatic STI among HIV-positive MSM and lessons for systematic screening.
    PLoS One. 2021;16:e0250557.
    >> Share

  348. ARUMUGAM A, Markham C, Aykar SS, Van Der Pol B, et al
    PrintrLab incubator: A portable and low-cost CO2 incubator based on an open-source 3D printer architecture.
    PLoS One. 2021;16:e0251812.
    >> Share

  349. OLIVER GR, Marcano-Bonilla S, Quist J, Tolosa EJ, et al
    LPCAT1-TERT fusions are uniquely recurrent in epithelioid trophoblastic tumors and positively regulate cell growth.
    PLoS One. 2021;16:e0250518.
    >> Share

  350. PARIS EA, Bahr JM, Bitterman P, Basu S, et al
    Incidence of malignant transformation in the oviductal fimbria in laying hens, a preclinical model of spontaneous ovarian cancer.
    PLoS One. 2021;16:e0255007.
    >> Share

  351. DEFANTE FERRETO LE, Guedes S, Braz Pauli F, Soligo Rovani S, et al
    Seroprevalence and associated factors of HIV and Hepatitis C in Brazilian high-security prisons: A state-wide epidemiological study.
    PLoS One. 2021;16:e0255173.
    >> Share

  352. WOROMOGO SH, Ambounda Ledaga N, Yagata-Moussa FE, Mihindou AS, et al
    Uterine cervical neoplasms mass screening at the University Hospital Centre of Libreville, Gabon: Associated factors with precancerous and cancerous lesions.
    PLoS One. 2021;16:e0255289.
    >> Share

  353. JU X, Canfell K, Howard K, Garvey G, et al
    Population-based utility scores for HPV infection and cervical squamous cell carcinoma among Australian Indigenous women.
    PLoS One. 2021;16:e0254575.
    >> Share

  354. HERNANDEZ-LOPEZ R, Hermosillo L, Leon-Maldonado L, Velazquez-Cruz R, et al
    Performance of an affordable urine self-sampling method for human papillomavirus detection in Mexican women.
    PLoS One. 2021;16:e0254946.
    >> Share

  355. ROSENBERG S, Callander D, Holt M, Duck-Chong L, et al
    Cisgenderism and transphobia in sexual health care and associations with testing for HIV and other sexually transmitted infections: Findings from the Australian Trans & Gender Diverse Sexual Health Survey.
    PLoS One. 2021;16:e0253589.
    >> Share

  356. ABDEL-MABOUD M, Menshawy A, Hasabo EA, Abdelraoof MI, et al
    The comparative effectiveness of 55 interventions in obese patients with polycystic ovary syndrome: A network meta-analysis of 101 randomized trials.
    PLoS One. 2021;16:e0254412.
    >> Share

  357. KOBAYASHI H, Matsubara S, Imanaka S
    Clinicopathological features of different subtypes in adenomyosis: Focus on early lesions.
    PLoS One. 2021;16:e0254147.
    >> Share

  358. KARAWEKPANYAWONG N, Kaewkitikul K, Maneeton B, Maneeton N, et al
    The prevalence of depressive disorder and its association in Thai cervical cancer patients.
    PLoS One. 2021;16:e0252779.
    >> Share

  359. KUMAR P, Srivastava S, Chauhan S, Patel R, et al
    Factors associated with gynaecological morbidities and treatment-seeking behaviour among adolescent girls residing in Bihar and Uttar Pradesh, India.
    PLoS One. 2021;16:e0252521.
    >> Share

  360. ANCHOORI RK, George L, Tseng SH, Lam B, et al
    Chirality and asymmetry increase the potency of candidate ADRM1/RPN13 inhibitors.
    PLoS One. 2021;16:e0256937.
    >> Share

  361. HANEM LGE, Salvesen O, Madsen A, Sagen JV, et al
    Maternal PCOS status and metformin in pregnancy: Steroid hormones in 5-10 years old children from the PregMet randomized controlled study.
    PLoS One. 2021;16:e0257186.
    >> Share

  362. PASANEN A, Loukovaara M, Ahvenainen T, Vahteristo P, et al
    Differential impact of clinicopathological risk factors within the 2 largest ProMisE molecular subgroups of endometrial carcinoma.
    PLoS One. 2021;16:e0253472.
    >> Share

  363. HARTMAN CA, Braganca JF, Gurgel MSC, Zeferino LC, et al
    Conservative treatment of microinvasive squamous cell carcinoma of the cervix stage IA1: Defining conization height to an optimal oncological outcome.
    PLoS One. 2021;16:e0253998.
    >> Share

  364. BEYENE T, Akibu M, Bekele H, Seyoum W, et al
    Risk factors for precancerous cervical lesion among women screened for cervical cancer in south Ethiopia: Unmatched case-control study.
    PLoS One. 2021;16:e0254663.
    >> Share

  365. TANAKA LF, Schriefer D, Radde K, Schauberger G, et al
    Impact of opportunistic screening on squamous cell and adenocarcinoma of the cervix in Germany: A population-based case-control study.
    PLoS One. 2021;16:e0253801.
    >> Share

  366. MANNING C, O'Neill C, Clarke IN, Rebec M, et al
    High-resolution genotyping of Lymphogranuloma Venereum (LGV) strains of Chlamydia trachomatis in London using multi-locus VNTR analysis-ompA genotyping (MLVA-ompA).
    PLoS One. 2021;16:e0254233.
    >> Share

  367. MOISE RK, Balise R, Ragin C, Kobetz E, et al
    Cervical cancer risk and access: Utilizing three statistical tools to assess Haitian women in South Florida.
    PLoS One. 2021;16:e0254089.
    >> Share

  368. CHIOSSI G, D'Amico R, Tramontano AL, Sampogna V, et al
    Prevalence of uterine rupture among women with one prior low transverse cesarean and women with unscarred uterus undergoing labor induction with PGE2: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0253957.
    >> Share

  369. DA-ANO R, Lucia F, Masson I, Abgral R, et al
    A transfer learning approach to facilitate ComBat-based harmonization of multicentre radiomic features in new datasets.
    PLoS One. 2021;16:e0253653.
    >> Share

  370. SAAVALAINEN L, Lassus H, But A, Gissler M, et al
    Incidence of extraovarian clear cell cancers in women with surgically diagnosed endometriosis: A cohort study.
    PLoS One. 2021;16:e0253270.
    >> Share

  371. ALISSA NA
    Knowledge and intentions regarding the Pap smear test among Saudi Arabian women.
    PLoS One. 2021;16:e0253850.
    >> Share

  372. LIM YJ, Lee HN
    Optimal use of radiotherapy in the definitive treatment of non-bulky IB-IIA cervical cancer: A population-based long-term survival analysis.
    PLoS One. 2021;16:e0253649.
    >> Share

  373. RAHMAN S, Wathington D, Waterboer T, Pawlita M, et al
    Seroprevalence of Chlamydia trachomatis, herpes simplex 2, Epstein-Barr virus, hepatitis C and associated factors among a cohort of men ages 18-70 years from three countries.
    PLoS One. 2021;16:e0253005.
    >> Share

  374. ONYWERA H, Anejo-Okopi J, Mwapagha LM, Okendo J, et al
    Predictive functional analysis reveals inferred features unique to cervicovaginal microbiota of African women with bacterial vaginosis and high-risk human papillomavirus infection.
    PLoS One. 2021;16:e0253218.
    >> Share

  375. GUI T, Yao C, Jia B, Shen K, et al
    Identification and analysis of genes associated with epithelial ovarian cancer by integrated bioinformatics methods.
    PLoS One. 2021;16:e0253136.
    >> Share

  376. SAWERI OPM, Batura N, Al Adawiyah R, Causer LM, et al
    Economic evaluation of point-of-care testing and treatment for sexually transmitted and genital infections in pregnancy in low- and middle-income countries: A systematic review.
    PLoS One. 2021;16:e0253135.
    >> Share

  377. OESCHGER TM, Erickson DC
    Visible colorimetric growth indicators of Neisseria gonorrhoeae for low-cost diagnostic applications.
    PLoS One. 2021;16:e0252961.
    >> Share

  378. MAGKANA M, Mentzelopoulou P, Magkana E, Pampanos A, et al
    The p16/ki-67 assay is a safe, effective and rapid approach to triage women with mild cervical lesions.
    PLoS One. 2021;16:e0253045.
    >> Share

  379. WALSH CS, Kamrava M, Rogatko A, Kim S, et al
    Phase II trial of cisplatin, gemcitabine and pembrolizumab for platinum-resistant ovarian cancer.
    PLoS One. 2021;16:e0252665.
    >> Share

  380. JAMISON CD, Greenwood-Ericksen M, Richardson CR, Choi H, et al
    Association between Chlamydia and routine place for healthcare in the United States: NHANES 1999-2016.
    PLoS One. 2021;16:e0251113.
    >> Share

  381. MIMOUN C, Paoletti X, Gaillard T, Crestani A, et al
    Using a new diagnostic tool to predict lymph node metastasis in advanced epithelial ovarian cancer leads to simple lymphadenectomy decision rules: A multicentre study from the FRANCOGYN group.
    PLoS One. 2021;16:e0258783.
    >> Share

  382. TORRES KL, Rondon HHMF, Martins TR, Martins S, et al
    Moving towards a strategy to accelerate cervical cancer elimination in a high-burden city-Lessons learned from the Amazon city of Manaus, Brazil.
    PLoS One. 2021;16:e0258539.
    >> Share

  383. ARDIZZONE CM, Albritton HL, Lillis RA, Bagnetto CEL, et al
    Human genital antibody-mediated inhibition of Chlamydia trachomatis infection and evidence for ompA genotype-specific neutralization.
    PLoS One. 2021;16:e0258759.
    >> Share

  384. ABBASIFARID E, Bolhassani A, Irani S, Sotoodehnejadnematalahi F, et al
    Synergistic effects of exosomal crocin or curcumin compounds and HPV L1-E7 polypeptide vaccine construct on tumor eradication in C57BL/6 mouse model.
    PLoS One. 2021;16:e0258599.
    >> Share

  385. NAJIOULLAH F, Dorival MJ, Joachim C, Dispagne C, et al
    Genotype distribution of cervical HPV among Caribbean women in a population-based study in Martinique: The DEPIPAPUFR study.
    PLoS One. 2021;16:e0257915.
    >> Share

  386. LARSSON C, Djuvfelt E, Lindam A, Tunon K, et al
    Surgical complications after caesarean section: A population-based cohort study.
    PLoS One. 2021;16:e0258222.
    >> Share

  387. SHIN HY, Song SY, Jun JK, Kim KY, et al
    Barriers and strategies for cervical cancer screening: What do female university students know and want?
    PLoS One. 2021;16:e0257529.
    >> Share

  388. ITKIN B, Garcia A, Straminsky S, Adelchanow ED, et al
    Prevalence of HER2 overexpression and amplification in cervical cancer: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0257976.
    >> Share

  389. CHEN PC, Li PC, Ding DC
    Pelvic inflammatory disease and causative pathogens in older women in a medical center in eastern Taiwan: A retrospective cross-sectional study.
    PLoS One. 2021;16:e0257627.
    >> Share

  390. SHIBATA T, Nakagawa M, Coleman HN, Owens SM, et al
    Evaluation of DNA extraction protocols from liquid-based cytology specimens for studying cervical microbiota.
    PLoS One. 2021;16:e0237556.
    >> Share

  391. MARRIE RA, Walld R, Bolton JM, Sareen J, et al
    Effect of comorbid mood and anxiety disorders on breast and cervical cancer screening in immune-mediated inflammatory disease.
    PLoS One. 2021;16:e0249809.
    >> Share

  392. MCCORKLE JR, Gorski JW, Liu J, Riggs MB, et al
    Lapatinib and poziotinib overcome ABCB1-mediated paclitaxel resistance in ovarian cancer.
    PLoS One. 2021;16:e0254205.
    >> Share

  393. CAMBOU MC, Saad E, McBride K, Fuller T, et al
    Maternal HIV and syphilis are not syndemic in Brazil: Hot spot analysis of the two epidemics.
    PLoS One. 2021;16:e0255590.
    >> Share

  394. TOWLE-MILLER LM, Miecznikowski JC, Zhang F, Tritchler DL, et al
    SuMO-Fil: Supervised multi-omic filtering prior to performing network analysis.
    PLoS One. 2021;16:e0255579.
    >> Share

  395. DAVIS AP, Maxwell CL, Mendoza H, Crooks A, et al
    Cognitive impairment in syphilis: Does treatment based on cerebrospinal fluid analysis improve outcome?
    PLoS One. 2021;16:e0254518.
    >> Share

  396. HANNA DH, R Saad G
    Induction of mitochondria mediated apoptosis in human ovarian cancer cells by folic acid coated tin oxide nanoparticles.
    PLoS One. 2021;16:e0258115.
    >> Share

  397. KEETILE M, Ndlovu K, Letamo G, Disang M, et al
    Factors associated with and socioeconomic inequalities in breast and cervical cancer screening among women aged 15-64 years in Botswana.
    PLoS One. 2021;16:e0255581.
    >> Share

  398. ABE M, Kinjo Y, Sadamoto S, Shinozaki M, et al
    alpha-galactosylceramide-stimulated invariant natural killer T-cells play a protective role in murine vulvovaginal candidiasis by Candida albicans.
    PLoS One. 2021;16:e0259306.
    >> Share

  399. DESTA M, Getaneh T, Yeserah B, Worku Y, et al
    Cervical cancer screening utilization and predictors among eligible women in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0259339.
    >> Share

  400. HARIMA Y, Ariga T, Kaneyasu Y, Ikushima H, et al
    Clinical value of serum biomarkers, squamous cell carcinoma antigen and apolipoprotein C-II in follow-up of patients with locally advanced cervical squamous cell carcinoma treated with radiation: A multicenter prospective cohort study.
    PLoS One. 2021;16:e0259235.
    >> Share

  401. ZUBERI Z, Mremi A, Chilongola JO, Semango G, et al
    Expression analysis of p16 and TOP2A protein biomarkers in cervical cancer lesions and their correlation with clinico-histopathological characteristics in a referral hospital, Tanzania.
    PLoS One. 2021;16:e0259096.
    >> Share

  402. SINCLAIR J, Collett L, Abbott J, Pate DW, et al
    Effects of cannabis ingestion on endometriosis-associated pelvic pain and related symptoms.
    PLoS One. 2021;16:e0258940.
    >> Share

  403. MULINGANYA G, De Vulder A, Bisimwa G, Boelens J, et al
    Prevalence, risk factors and adverse pregnancy outcomes of second trimester bacterial vaginosis among pregnant women in Bukavu, Democratic Republic of the Congo.
    PLoS One. 2021;16:e0257939.
    >> Share

  404. KUGUYO O, Dube Mandishora RS, Thomford NE, Makunike-Mutasa R, et al
    High-risk HPV genotypes in Zimbabwean women with cervical cancer: Comparative analyses between HIV-negative and HIV-positive women.
    PLoS One. 2021;16:e0257324.
    >> Share

  405. JAREID M, Snapkov I, Holden M, Busund LR, et al
    The blood transcriptome prior to ovarian cancer diagnosis: A case-control study in the NOWAC postgenome cohort.
    PLoS One. 2021;16:e0256442.
    >> Share

  406. LIN KY, Yang CY, Lam A, Chang CY, et al
    Uterine leiomyoma is associated with the risk of developing endometriosis: A nationwide cohort study involving 156,195 women.
    PLoS One. 2021;16:e0256772.
    >> Share

  407. TURNER E, Sobel JD, Akins RA
    Prognosis of recurrent bacterial vaginosis based on longitudinal changes in abundance of Lactobacillus and specific species of Gardnerella.
    PLoS One. 2021;16:e0256445.
    >> Share

  408. KARGASHEH FB, Ansaripour S, Borumandnia N, Moradi N, et al
    Association of leptin G2548A and leptin receptor Q223R polymorphisms and their serum levels with infertility and recurrent pregnancy loss in Iranian women with polycystic ovary syndrome.
    PLoS One. 2021;16:e0255920.
    >> Share

  409. PONCET L, Panjo H, Ringa V, Andro A, et al
    Do vulnerable groups access prevention services? Cervical cancer screening and HIV testing among homeless migrant women in the Paris metropolitan area.
    PLoS One. 2021;16:e0255900.
    >> Share

  410. KAUR I, Suri V, Rana SV, Singh A, et al
    Treatment pathways traversed by polycystic ovary syndrome (PCOS) patients: A mixed-method study.
    PLoS One. 2021;16:e0255830.
    >> Share

  411. ALKHARUSI A, AlMuslahi A, AlBalushi N, AlAjmi R, et al
    Connections between prolactin and ovarian cancer.
    PLoS One. 2021;16:e0255701.
    >> Share

  412. CIRILLO PDR, Margiotti K, Fabiani M, Barros-Filho MC, et al
    Multi-analytical test based on serum miRNAs and proteins quantification for ovarian cancer early detection.
    PLoS One. 2021;16:e0255804.
    >> Share

  413. WU Y, Peng T, Chen Y, Huang L, et al
    Acupuncture for glucose and lipid metabolic disorders of polycystic ovarian syndrome: A systematic review protocol.
    PLoS One. 2021;16:e0255732.
    >> Share

  414. SAEED-VAFA D, Marchion DC, McCarthy SM, Hakam A, et al
    Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clinical outcomes.
    PLoS One. 2021;16:e0256615.
    >> Share

  415. HU B, Dong Y, Zhou W, Ma Y, et al
    Effect of Inonotus obliquus polysaccharide on composition of the intestinal flora in mice with acute endometritis.
    PLoS One. 2021;16:e0259570.
    >> Share

  416. LIU NT, Perng CL, Chou YC, Ko PS, et al
    Loss of ten-eleven translocation 1 (TET1) expression as a diagnostic and prognostic biomarker of endometrial carcinoma.
    PLoS One. 2021;16:e0259330.
    >> Share

  417. GRASSI T, Harris FR, Smadbeck JB, Murphy SJ, et al
    Personalized tumor-specific DNA junctions to detect circulating tumor in patients with endometrial cancer.
    PLoS One. 2021;16:e0252390.
    >> Share

  418. BORGOGNA JC, Anastario M, Firemoon P, Rink E, et al
    Vaginal microbiota of American Indian women and associations with measures of psychosocial stress.
    PLoS One. 2021;16:e0260813.
    >> Share

  419. KRAMER KJ, Ottum S, Gonullu D, Bell C, et al
    Reoperation rates for recurrence of fibroids after abdominal myomectomy in women with large uterus.
    PLoS One. 2021;16:e0261085.
    >> Share

  420. SIEGEL EM, Ajidahun A, Berglund A, Guerrero W, et al
    Genome-wide host methylation profiling of anal and cervical carcinoma.
    PLoS One. 2021;16:e0260857.
    >> Share

  421. WONG DH, Mardock AL, Manrriquez EN, Lai TS, et al
    Trends in extent of surgical cytoreduction for patients with ovarian cancer.
    PLoS One. 2021;16:e0260255.
    >> Share

  422. SINGINI MG, Sitas F, Bradshaw D, Chen WC, et al
    Ranking lifestyle risk factors for cervical cancer among Black women: A case-control study from Johannesburg, South Africa.
    PLoS One. 2021;16:e0260319.
    >> Share

  423. NODA-NICOLAU NM, Silva MC, Bento GFC, Ferreira JSB, et al
    Cervicovaginal levels of human beta defensins during bacterial vaginosis.
    PLoS One. 2021;16:e0260753.
    >> Share

  424. YESSOUFOU K, Ambani AE, Elansary HO, Gaoue OG, et al
    Alien woody plants are more versatile than native, but both share similar therapeutic redundancy in South Africa.
    PLoS One. 2021;16:e0260390.
    >> Share

  425. KAUR P, Nagar S, Bhagwat M, Uddin M, et al
    Activated heme synthesis regulates glycolysis and oxidative metabolism in breast and ovarian cancer cells.
    PLoS One. 2021;16:e0260400.
    >> Share

  426. GRESSEL GM, Usyk M, Frimer M, Kuo DYS, et al
    Characterization of the endometrial, cervicovaginal and anorectal microbiota in post-menopausal women with endometrioid and serous endometrial cancers.
    PLoS One. 2021;16:e0259188.
    >> Share

  427. BAEDYANANDA F, Chaiwongkot A, Varadarajan S, Bhattarakosol P, et al
    HPV16 E1 dysregulated cellular genes involved in cell proliferation and host DNA damage: A possible role in cervical carcinogenesis.
    PLoS One. 2021;16:e0260841.
    >> Share

  428. SALAMUN V, Bokal EV, Maver A, Papler TB, et al
    Transcriptome study of receptive endometrium in overweight and obese women shows important expression differences in immune response and inflammatory pathways in women who do not conceive.
    PLoS One. 2021;16:e0261873.
    >> Share

  429. BENJAMIN JJ, K M, Koshy T, K N M, et al
    DHEA and polycystic ovarian syndrome: Meta-analysis of case-control studies.
    PLoS One. 2021;16:e0261552.
    >> Share

  430. BALEYDIER I, Vassilakos P, Vinals R, Wisniak A, et al
    Study protocol for a two-site clinical trial to validate a smartphone-based artificial intelligence classifier identifying cervical precancer and cancer in HPV-positive women in Cameroon.
    PLoS One. 2021;16:e0260776.
    >> Share

  431. LIM ZW, Wang ID, Wang P, Chung CH, et al
    Obstructive sleep apnea increases risk of female infertility: A 14-year nationwide population-based study.
    PLoS One. 2021;16:e0260842.
    >> Share

  432. HUSAIYIN S, Jiao Z, Yimamu K, Maisaidi R, et al
    ThinPrep cytology combined with HPV detection in the diagnosis of cervical lesions in 1622 patients.
    PLoS One. 2021;16:e0260915.
    >> Share

  433. MOSTAID MS, Mumu SB, Haque MA, Sharmin S, et al
    Elevated serum expression of p53 and association of TP53 codon 72 polymorphisms with risk of cervical cancer in Bangladeshi women.
    PLoS One. 2021;16:e0261984.
    >> Share

  434. LE N, Cregger M, Brown V, Loret de Mola J, et al
    Association of microbial dynamics with urinary estrogens and estrogen metabolites in patients with endometriosis.
    PLoS One. 2021;16:e0261362.
    >> Share

  435. ISSA T, Babi A, Issanov A, Akilzhanova A, et al
    Knowledge and awareness of human papillomavirus infection and human papillomavirus vaccine among Kazakhstani women attending gynecological clinics.
    PLoS One. 2021;16:e0261203.
    >> Share

  436. CAMUS C, Penaranda G, Khiri H, Camiade S, et al
    Acceptability and efficacy of vaginal self-sampling for genital infection and bacterial vaginosis: A cross-sectional study.
    PLoS One. 2021;16:e0260021.
    >> Share

  437. PRAHM KP, Hogdall CK, Karlsen MA, Christensen IJ, et al
    MicroRNA characteristics in epithelial ovarian cancer.
    PLoS One. 2021;16:e0252401.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016